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ABSTRACT
The present dissertation contains a collection of studies that examine the genomic, proteomic,
and metabolomic association to pulmonary hypertension or ascites phenotype in fast-growing
broilers. Pulmonary hypertension is a multifactorial metabolic disease influenced by
physiological, environmental, and nutritional factors. It is characterized by a number of
structural changes including, thrombosis and adverse pulmonary vascular remodeling. Thus, the
atrial pressure is increased, and the right ventricle becomes hypertrophied, resulting in heart
failure and the death of the bird. Pulmonary hypertension or ascites is a global problem that has
negatively impacted the economy. The increased mortality rate of broilers (25%) is estimated to
cost $1 billion per year in economic losses. Even though molecular genetic techniques were used
in the breeding and selection, they have significantly reduced the occurrence of ascites, but not
fully eradicated it. Hence, the main objective of this dissertation was to: measure the expression
of the CPQ gene in eight tissues (heart, liver, kidney, thigh, breast, spleen, lung, thymus) to
investigate the possible effect of a specific genotype on the gene expression, develop a TaqMan
assay for the 125 Kbp chromosomal deletion of CPQ gene to test the potential associations with
ascites phenotype, and to identify noninvasive biomarkers for early ascites detection by
examining the proteomic and metabolomic changes prior and post ascites development.
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CHAPTER 1
Literature Review

1

The History of the Domestic Chickens
Chickens are rich in several ideal nutrients because they mainly contain proteins in both
products (meat and eggs), a good source of energy, and the best dietary source of several vitamins
and minerals (Marangoni et al., 2015). According to several studies, a chicken diet helps
consumers reduce body weight and obesity, decrease the incidence of cardiovascular disease, and
lower the risk of developing Type 2 diabetes (Hu et al., 2005). Archaeological, morphological, and
historical evidence proved that chickens were domesticated in Southeast Asia more than 5,400
years ago (Darwin et al.,1875; Fumihito et al., 1996; Storey et al., 2012). Then, domestic chickens
reached China, Europe, and Western Asia (Granevitze et al., 2009; Tixier-Boichard et al., 2011).
Genetic studies based on mitochondrial DNAs (mtDNA) sequences from several gallinaceous
birds, the red junglefowl (RJF, Gallus gallus gallus) is the prominent ancestor of the domestic
chickens (Fumihito et al., 1994; Hillel et al., 2003). However, other mitochondrial and genomic
studies show that other ancestors participate in the history of domestic chickens (Nishibori et al.,
2005; Oka et al., 2007; Miao et al., 2013). In addition, mtDNAs have a low ability to identify
detailed demographics from the past (Larson, & Burger, 2013). On the other hand, other modern
techniques such as Whole Genome Resequencing are promising for revealing a complete story of
the domestication process (Wang et al., 2016). There is a controversial issue about which, where,
and when, were the domestic chickens originally descended. Theories on domestic chickens
originating from RJF, (Gallus gallus) in different sites in Southeast Asia are still questionable
(Wang et al., 2020). In addition to the RJF, Ceylon jungle fowl, Java or green jungle fowl, and
grey jungle fowl are other major Gallus species mentioned in the literature. Each species has
different characteristics, and early domestication has influenced genotyping (Stevens & Lewis
1991). Religious and cultural reasons, food, and decoration were the main aims behind the initial
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domestication of chickens in the Middle East, Africa, and Southeast Asia. Moreover, in the United
States and Europe, chickens became popular because they have been used to study human diseases.
Domestic Chickens in the Industry
In the USA, broiler production increased from 413 million to 1.1 billion bounds between
1940 to 1945. Alabama, Georgia, and Arkansas are the highest states in broilers production,
producing broilers for many decades (Figure 1.1). According to the US Department of Agriculture,
the USA is the first chicken producer globally and the biggest exporter after Brazil. In 2013, the
chicken production in the USA poultry industry reached 8.22 billion broilers, and their weight was
50.6 billion pounds. In Europe, especially in Netherlands and Germany, the demand for American
broilers has continued to grow. Therefore, 173 million pounds were produced (Bishop et al., 2015).
In the 1940s, chickens required a long time (approximately 16 weeks) to achieve the desired weight
(2 to 2.5 kg). After selective breeding was incorporated, broilers reached the standard weight
within less than seven weeks (Bugos, 1992; Griffin et al.,1994; Bishop et al., 2015).
Chickens, in general, were selected in the 1990s for particular traits such as eggs and meat
production in both Europe and the USA. The selection occurred at that time due to the fact that
RJF has a lower-body weight (about two pounds) and lays 10 to 12 eggs/ year. Because of intensive
genetic selections, which have been done through several generations within broiler lines (meattype chickens) and layer lines (egg production type), the current commercial broilers have a higher
body weight (~ 4 times) and grater breast muscle (~8 times) than un-selected ones. Furthermore,
egg-type chickens can lay more than 300 eggs/ year. The genetic selection also increases the
production of both main pectoralis muscles by 79% in males and 85% in males and minor
pectoralis muscles by 30% in males and 37% in females. Selective breeding helps study the
mechanism of tissue growth, lowering the time and reducing the costs of raising each flock,
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including food, housing, heating, and lighting. In addition, breeding in the poultry industry has
other advantages such as high selection intensity, which can be done in a short time and at a large
scale (Griffin et al.,1994; Deeb et al., 2002; Zuidhof et al., 2005; Jacob et al., 2011; Buzala et al.,
2016). As shown in Figure1.2, from 1925 to 2012, broilers almost doubled in weight, the number
of weeks required to reach market weight has decreased by 56%, the feed needed per pound of
chickens have been dropped by 61%, and the mortality rate has been reduced by 78% (Bishop et
al., 2015). Chicken consumption among Americans has increased since 2012, while there was a
decline in the consumption of both pork and beef (Figure 1.3) (Larsen, 2012).
Since the 1990s, several breeding companies have been established, and a large number of
geneticists have been employed. In the early stage of genetic selections, geneticists improved the
random breeding by using white broilers such as Athens Canadian Random Bred Control
(ACRBC) as the experimental population (Havenstein et al., 2003). That gives a better result, such
as changing the bird’s phenotype, reducing mortality rate, and controlling diseases (Flock et al.,
2005). However, unexpected results of practicing genetic selection can alter the bird’s traits
because the gene of interest can be linked with an undesirable gene (Ellegren, 2005). Moreover,
various metabolic diseases associated with genetic selection and rapid growth have existed in the
poultry industry for more than 30 years. That has negatively impacted the poultry industry. Ascites
or Pulmonary Arterial Hypertension (PAH), Fatty Liver and Kidney Syndrome (FLKS), skeleton
diseases (Griffin, 1993), and immune disorders are examples of diseases that affect the poultry
industry (Leshchinsky, & Klasing, 2001).
The poultry breeding and production system developed by modern poultry breeding
companies can be visualized in a pyramidal breeding structure (Figure 1.4). The pure pedigreed
line is at the top of the pyramid scheme, and each level indicates one generation. Cobb-Vantress
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company is an example of a modern poultry breeding company. It generates over 50
birds/pedigree. These birds are precisely evaluated for their phenotypes, health, and fitness (Flock
et al., 2005; Laughlin et al., 2007; Paxton et al., 2010; Katanbaf et al., 2010). The pure pedigree
line, which consists of a small population, gives the parental generation of the great grandparents’
stock. Then, the great grandparents provide the generation of the grandparents’ stock. The first
crossing, in the pyramid scheme, occurs between the grandparents’ levels. Then, the parents are
mated to provide the commercial broilers, which will be available in the poultry industries for meat
and egg production. As shown in Figure 1.5, the pure pedigree line mainly consists of two major
lines of both sexes. The four populations are maintained under specific genetic selections to
improve some economic traits such as meat production and growth rate in male populations while
egg production and growth rate in female populations. The four populations used the great
grandparents to produce grandparents’ stock (first hybrid). Then, the grandparents produce the
parents (second hybrid). Finally, the parent’s generation is mated to produce the commercial
broilers (double hybrid). Based on some statistical studies, there was an estimation of 400,000
pedigree birds, which represent a range of 35 to 40 pure lines, are the major ancestor of
approximately 400,000 million broilers (Pollock, 1999).
If a conventional breeding scheme or natural selection is followed today, the broilers
should be fed with high-efficiency feed. Broilers are allowed to consume a large quantity of food
for the first two weeks to maximize their skeleton before more muscle is obtained. The general
public has the misconception that hormones, which are illegal not only in the USA but also in the
majority of other countries, are a major part of broilers' diets and are in charge of their rapid growth.
Broilers grow quickly due to their breeding improvement, good management, and nutrition (Jacob
et al., 2011).
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The Chicken Genome
We have expanded our knowledge about avian genomics in the last few years since several
articles related to avian genome sequencing have been published (Bravo et al., 2021). The first
bird and domesticated animal whose genome has been sequenced is the chicken. To begin with, a
proposal was approved in 2002 by the National Human Genome Research Institute to sequence
the chicken genome. As a result, the Genome Sequencing Center at Washington University's
medical school sequenced around 1.2 billion bp in 2003 utilizing a Whole Genome Sequencing
method that specialized in Sanger sequencing. Then, after one year, the preliminary results of the
genome sequences were published and available to public databases. A DNA from an inbred strain
of female RJF Gallus gallus was chosen to create the first genome sequencing draft (Fumihito et
al., 1994; Ellegren, 2005; Groenen et al., 2009). Even though this draft represents approximately
86% coverage of the chicken genome, the major histocompatibility complex (MHC) on
chromosome 16 and the single copy of the sex chromosomes (Z and W chromosomes) were poorly
represented as well as 5 % to 10% of genes were not included in the assembly (Burt, 2005). The
avian genome reference assembly has been improved over time due to having more effective
genome assembly software, which helps remove artifacts. The new chicken genome assembly
(Gallus gallus 5.0) was published in 2015 (Ye et al., 2011; Schmid et al., 2015). According to early
studies, bird genomes are substantially smaller than mammalian genomes. The size of a chicken
genome is 1230.26 MB which is approximately one-third the size of the mammalian genome with
an estimated range of 20,000 to 23,000 genes, while the size of the chicken mitochondrial genome
is 16.775 MB (Desjardins et al., 1990; Waltari et al., 2002; Ellegren, 2005). Though the
evolutionary significance of this variation is unknown, one theory suggests that birds’ limited
genome size evolved to meet their physiological demands on flight (Butler, 2016). The karyotype
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of chicken is made up of 39 chromosome pairs, as shown in Figure 1.6: there are ten pairs of large
autosomes (chromosomes 1-10), 28 pairs of microchromosomes (chromosomes 11-38), and one
pair of sex chromosomes (chromosome W and Z). Males carry two copies of chromosome Z (ZZ),
whereas females carry only one copy of chromosome Z and one copy of chromosome W (ZW)
(Masabanda et al., 2004).
There are some motivating factors in sequencing the chicken genome. First, the chicken,
which descended from dinosaurs 310 million years ago, is the first non-mammalian vertebrate
sequenced. The evolutionary tree of life includes chickens as well. Secondly, understanding
chickens' genomes helps provide a general picture of how genes in vertebrates have developed and
been modified. By classifying the chicken as an outgroup, it is easy to distinguish the ancient traits
of mammalian biology. The chicken is an excellent model for biomedical research. They also have
been used in several biological studies, especially in developmental biology, including the
embryonic development of vertebrates, and studying distinct branches of biology, including
immunology, virology, microbiology, and oncogenesis (Brown et al., 2003). Moreover, the
chicken is significant for agriculture because it is one of the primary sources of proteins, and
having its genome sequenced would help identify Quantitative Traits Locus (QTL) related to either
meat or egg production and animal health (International Chicken Genome Sequencing
Consortium, 2004; Burt, 2005).
Using the single nucleotide polymorphisms (SNPs) in the genomic project enables a large
portion of the whole genomic variation to be identified and evaluated. It can be accomplished by
examining several unlinked regions in synonymous and non-synonymous SNPs (Eltanany & Distl,
2010). Besides sequencing the chicken genome, a genetic variation map was generated 2.8 million
SNPs based on comparing three different types of domestic chickens (broiler, layer, Silkie) to their
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common ancestor RJF (International Chicken Polymorphism Map Consortium, 2004). Further
studies proved that almost 90% of the SNPs are valid, while 70% are common SNPs that
differentiate between various domestic breeds. In other words, the nucleotide variation between
these domestic chickens and RJF is 5 SNP/kb, which means that three domestic chickens are
extremely inbred relative to their ancestor (Groenen et al., 2000; Muir et al., 2003). The chicken
genome contains more SNPs than mammals. Research suggests the chicken genome acquires six
times the number of SNPs (~7,000,000 SNPs) than the mammalian genome and contains a
significant number of microsatellites (~375,000) (Eltanany & Distl, 2010). SNPs are responsible
for genetic diversity. Therefore, SNP arrays have been widely used to study the population’s
genetic structure using many uniformly distributed markers on all chromosomes. This method
allows the identification and mapping of a large number of copy number variations (CNVs) on the
genome (Muir et al., 2008; Gärke et al., 2012). Various genetic resources for chickens with
excellent coverage are available and have been improved by bacterial artificial chromosome
(BAC) based library production (Wallis et al., 2004). The development of QTL is significant
because it contributes to identifying molecular markers associated with phenotypic variations and
diseases (Hocking, 2005). QTL is a genetic locus on a chromosome where allelic variation is
statistically linked to particular phenotypes. Scientists identify QTL by comparing the genetic
make-up and certain features of the targeted group to the control group. Then, they use a statistical
test to assess if a DNA region or certain gene is involved in the trait of interest (Grisel,2000).
Macrochromosomal traits, chromosome distribution, and genomic size has been defined using a
combination of genetic and physical mapping (Ladjali-Mohammedi et al., 1999). Currently,
whole-genome sequencing (WGS) and genome-wide association studies (GWAS) are two
practical approaches for determining a chromosomal region that is linked to the trait of interest
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through building a genetic map with a high density (Gheyas et al., 2013; Liz et al., 2016). The
genetic map can be used for QTL mapping associated with several commercial features mentioned
earlier (Wong et al., 2004; Hillier et al., 2004).
Genetic Selection in the Poultry Industry
Current genotyping technologies with the development of molecular genetics has made it
possible to integrate molecular data into animal genetic improvement. Moreover, these strategies
allow switching to the use of markers that are in linkage disequilibrium through the population
(Dekkers, 2005). Over the last 60 years, the program of genetic selection has resulted in a faster
development rate and improved meat production in broilers (meat-type chickens), lowering the
slaughter age, decreasing the energy and the amount of feed necessary to produce birds with the
desired weight (Bradshaw et al., 2002; Tallentire et al., 2016). From 1975 to 2005, the rate of
growth grew by more than 400% (Zuidhof et al., 2014), and almost 85-90% of this growth was
due to genetic selection (Havenstein et al., 2003). This remarkable achievement was accomplished
by phenotypic selection and breeding based on an estimation of breeding values (EBV) without
knowing the number of genes (Dekkers, 2005). Utilizing this would increase the frequency of the
beneficial alleles or decrease the frequency of the undesirable ones. (Meuwissen et al., 2001). Due
to the publishing of the chicken genome sequence in 2004 and having advanced technology with
an excellent computing system, several poultry breeding industries were highly interested in using
the genomic data to help them in selecting and breeding. Since Mendel proposed the possibility of
what we call “internal variables” that can be passed down from generation to generation, the link
between genotypic and phenotypic makeup has sparked a biological interest. In the past few years,
a large number of technologies have been enhanced to detect DNA variations and have a better
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understanding of how DNA variation influences traits. As a result, various strategies and
methodologies have been improved and participated in enhancing breeding programs.
Restriction Fragment Length Polymorphisms (RFLPs)
Restriction Fragment Length Polymorphisms (RFLPs) were the first molecular techniques
that allow genetic mapping and identifying individuals based on genetic variations through using
restriction enzyme-digested DNA and probes for certain genes or genomic dispersed repetitive
elements (Powell et al., 1996; Edwards et al., 2007). This approach was successful in detecting
significant deletions or insertions in DNA, as well as single base alterations within the restriction
enzyme digesting site. Furthermore, RFLPs were used to detect DNA variations that impact
commercially important traits. This technique was used to identify gene location, diagnose the
genetic disorder, and determine parentage. Nevertheless, this method was too expensive and timeconsuming, which limited individuals’ numbers that can be genotyped. Thus, RFLPs were not
recently used in the poultry breeding industries (Lamont, 1990; Fulton, 2012).
Microsatellites (MS) or Simple Sequence Tandem Repeats (SSTRs)
Since the development of the polymerase chain reaction (PCR), it can be easy to amplify a
minimal amount of the DNA. Microsatellites (MS) or simple sequence tandem repeats (SSTRs),
which were used as a molecular marker, are short repetitive DNA sequences of short length. These
repetitive sequences can be detected by PCR (Powell et al., 1996; Milan et al., 1998; Hillel et al.,
2003; Dalvit et al., 2008; Li et al., 2004). Then, the amplified region or PCR product can be further
examined using polyacrylamide gel electrophoresis (PAGE) with a high throughput property
(Suwabe et al., 2002; Wang et al., 2003). MS is multiallelic, codominant, and extremely
polymorphic. MS is widely distributed across the genome (Fulton, 2012). It has been proven that
MS plays an important role not only in identifying genetic variations but also in determining the
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phylogenetic tree of some organisms within the same species (Buchanan et al., 1994; Vanhala et
al., 1998). All the previous characteristics suggested that microsatellites can be an excellent
selection marker. However, detecting MS at first was prohibitively costly. later, the cost had been
dramatically dropped once they have been identified. An MS-based genomic map was highly
improved to uncover genetic regions associated with different commercial traits, but these regions
were too large, including hundreds of genes. Even though the given number of MS markers and
the experimental population sizes were inadequate to help to determine the gene of interest, this
initial study revealed those genetic variations that are responsible for commercial traits could be
identified (Fulton, 2012). MS can be affected by some major evolutionary mechanisms involving
gene flow, mutations, and genetic drift, but natural selection does not have any impact on MS
(Kikuchi et al., 2002; Estoup et al., 2002).
Quantitative Trait Loci (QTL)
Quantitative trait locus (QTL), which is a statistical tool, shows the relationship between
two various types of data, including genotypic information or molecular markers and phenotypic
information or trait measurements. The main purpose of QTL is to show why there is a variation
in some complex phenotypes and what are the genetic basis behind that. Furthermore, this
approach can provide more specific details about not only gene positions but also genetic
interactions and gene numbers (Kearsey; Lynch et al., 1998; Miles et al., 2008). The easiest way
is to do a single marker analysis where each marker locus has a range of trait values that are
different from other markers. Although the analysis of variance (ANOVA) has been widely used
to find QTL, it does not predict both sizes and positions of the QTL effect (Jones et al., 2006).
QTL mapping is beneficial for different fields of study involving evolution, agriculture, and
medicine (Miles et al., 2008). Moreover, QTL analyses are a powerful tool for identifying genomic

11

regions that co-segregate within a particular trait in F2 generations or the family of Recombinant
Inbred Line (RIL) (Alonso-Blanco et al., 1998; Kowalski et al., 1994). To demonstrate, scientists
need two factors to start a QTL analysis. First, they require at least two different types of organisms
with genetic differences in the trait of interest. Second, they must have genetic markers for
genotyping purposes. Various types of markers have been used for QTL mapping involving MS,
RFLPs, SNPs, and transposable element positions (Casa et al., 2000; Vignal et al., 2002; Henry,
2006; Miles et al., 2008). To start the QTL mapping, the heterozygous F1 individuals are crossed
based on a specific breeding scheme. Then, the new generations (F2) are scored for genotypes and
phenotypes. Genetic markers associated with QTL can influence the trait of interest only if they
show a high allelic frequency. To determine the QTL for a trait influenced by many genes (it could
be tens or even hundreds of genes), the parental lines should have the same traits with different
alleles. Then, the F1 generation can be reassorted based on recombinant alleles with distinct
phenotypic values (Miles et al., 2008). Scientists were able to identify QTL associated with
evolution or ecology for unmanipulated natural populations through using sibships, pedigree, and
hybrids information (Mott et al., 2000; Slate, 2005; Shaw et al., 2007; Baack et al., 2008). Ten
years ago, the animal genome QTL database (http://www.animalgenome.org) published 125
articles discovering over 2,400 QTL for 248 phenotypes. The phenotypes that underwent studies
were related to metabolic disorders, egg quality and production, growth, specific disease
resistance, and chickens’ behavior. The majority of all these QTL analyses were determined using
200 to 350 of MS as well as creating new lines by doing multiple crosses between different types
of breeds, including broilers and egg-laying chickens. The control regions, which have been
observed between new lines, are responsible for the large phenotypic variations. Only a few breed
QTL studies were published, and it is possible that different poultry breeding companies conducted
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further studies which have not been reported in the literature (Fulton, 2012). There are two main
issues in QTL mapping. First, the ability to identify a QTL depends on the sample size,
experimental design, and the type of statistical approach used for data analysis (Majumde et al.,
2005). The second issue is what are the nature and marker distributions of chromosomes (Gibbs et
al., 2003; Wall et al., 2003). There are other issues in QTL mapping that can affect the
determination of phenotypic values, including genotype-environment interactions and gene-gene
interactions or epistasis (Majumde et al., 2005). Since 2003, QTL mapping has been expanded to
include more informative results such as measuring the gene expression or eQTL and knowing the
protein quantity produced by specific genes or pQTL (Schadt et al., 2003; Foss et al., 2007;
Cheverud et al., 2008).
Marker-Assisted Selection (MAS) in Poultry
Marker-Assisted Selection (MAS) is a branch of molecular breeding (MB) that has been
defined as the application of genetic manipulation at a molecular level to enhance the traits of
interest not only in animals but also in plants (Ribaut et al., 2010; Jiang et al., 2013). To apply the
MAS in poultry, several studies have been done in chickens using markers with a random
distribution in the genome or MS. This helps in identifying a large number of QTL related to meat
production (Tatsuda et al., 2001; Nones et al., 2006; Ambo et al., 2008; Campos et al., 2009).
Other researchers have focused on identifying SNPs in functional genes and assessed their
relationship with targeted QTL (Boschiero et al., 2013; Felício et al., 2013; Pértille et al., 2015).
In the past few years, next-generation sequencing (NGS) has become popular since it has been
used to conduct GWAS to identify a novel QTL as well as update regions mentioned in the
literature (Sun et al.; Morris et al., 2013; Park et al., 2013; Moreira et al.; Godoy et al., 2015;
Pértille et al., 2017). The aim was to use the previous information for MAS since several significant
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genomic regions related to the traits of interest have been identified. Then, individuals with
superior performance were chosen at an early age based on specific DNA markers. Although these
DNA markers used for selection might not be the main cause for phenotypic variations, they were
at least close to the targeted regions that could be used for selection (Fulton, 2012). MAS has been
widely used in the breeding programs of chicken industries. They used MAS to reduce the
frequency of undesirable alleles or enhance the frequency of the beneficial alleles (Meuwissen et
al., 2001; Siegel et al., 2006). For example, MAS has some practical restrictions. To begin with,
recombination might appear in the next generations only if the DNA markers were not close to the
region of interest, such as a lack of positive correlation between a marker allele and a significant
trait. Moreover, the correlation between a marker allele and a significant trait was family or
population specific. This has created several MAS limitations within pure line populations. The
negative association between two or more traits other than the trait of interest was the other
problem with MAS. For instance, the major goal of the commercial breeding program through
MAS is to have a bird of good quality. However, MAS for large eggs might have other unfavorable
traits such as markers responsible for feed efficiency, shell strength, or body weight (Fulton, 2012).
Genome-Wide Association Studies (GWAS)
Genome-Wide Association Studies (GWAS) are a complementary and powerful approach
to QTL mapping (Zhang et al., 2014). GWAS looks for genetic variations associated with a disease
of interest in two different groups (disease cases and unaffected control). It has been possible to
do GWAS due to identifying large numbers of SNPs across the genome as well as realizing that
the majority of these SNPs can determine prevalent genetic variations (Gibbs et al., 2003; Witte,
2010). Gu et al. conducted GWAS to identify SNPs associated with body weight in chickens. They
used an F2 resource population that has been developed from White Plymouth Rock X Silky Fowl;
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they found that several important SNPs can cause late growth at 7-12 weeks of age. These SNPs,
which are in chromosome 4, are associated with LIM domain-binding factor 2 (LDB2) gene
(2011). Another study has shown that there are seven SNPs and four genes located in the same
region (chromosome 4) and related to body weight. These genes are Leucine Aminopeptidase 3
(LAP3), Transmembrane Anterior-Posterior Transformation 1(TAPT1), LIM Domain Binding 2
(LDB2), and Ligand Dependent Nuclear Receptor Corepressor Like (LCORL) (Liu et al., 2013).
A group of scientists has conducted GWAS on F2 crosses between a fast-growing commercial
broiler (Cobb-Vantress) and a local Chinese breed (Beijing-You chickens). They found that there
are 14 genes responsible for meat quality traits. Some of these genes are microsomal glutathione
S-transferase 1 (MGST1), natriuretic peptide B (NPPB), sterol regulatory element-binding
transcription factor 1 (SREBF1), and protein tyrosine kinase (TYRO3) (Sun et al., 2013). GWAS
has become popular recently in genetic research, and before that, linkage and candidate gene
studies were used to find the genetic basis of diseases (Botstein et al., 1980). Linkage studies have
a lower power because they assess markers widely distributed across the genome to see if these
markers are passed to the next generations or not. Moreover, linkage studies are not able to uncover
disease-related genetic risk factors. Candidate gene studies focus on the relationship between
genetic variations and disease of interest, but they skip most of the genome. Consequently,
candidate gene studies can miss a lot of causative regions or genes and detect a lot of false-positive
associations (Hirschhorn et al., 2002; Lohmueller et al., 2003). GWAS has more power than the
two previous approaches because GWAS has successfully identified hundreds of variations linked
to great numbers of diseases. Most of these variations are novel; chromosomal regions or related
SNPs in genes have never been linked to the disease before (Hindorff et al., 2009). Although
GWAS represents an improvement over the limitations of QTL studies, they introduce other issues.
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However, when they are carried out together, they can correct each other’s limitations (Korte et
al., 2013). QTLs have hundreds of related genes, while GWAS generates a significant number of
unrelated genes or nucleotides. Even though GWAS are restricted to organisms with genetic
resources, a combination of these two approaches has a beneficial advantage through enhancing
the statistical power with great mapping of linked genes or even nucleotides (Miles et al., 2008).
Currently, next-generation sequencing (NGS) and DNA hybridization help in identifying
significant structural variations known as number variation (CNV). The CNV is a genomic
polymorphism that results in changing the number of copies of DNA through duplications or
insertions and deletions (INDELs). The CNV usually ranges from 1kbp to 5Mbp and is one of the
most important contributors to phenotypic variations in plants and animals (Clop et al., 2012; Yan
et al., 2014). A large number of studies have been conducted to prove that CNV is responsible for
several human diseases such as autism spectrum disorders, cardiovascular diseases, and peripheral
arterial diseases (Pollex et al., 2007; Girirajan et al., 2013; Koller et al., 2020).
Single Nucleotide Polymorphisms (SNPs)
Approximately 2.8 million single nucleotide polymorphisms (SNPs) were identified and
published by the Beijing Genome Institute once the 2004 chicken genome had been released. SNPs
are “single nucleotide variants within the DNA sequence,” and INDELs account for almost 10%
of these variants (Brandstrom et al., 2007; Fulton, 2011; Yan et al., 2014). SNPs can be either
heterozygous or homozygous. The simplest way of SNP genotyping after targeting a particular
region containing a candidate gene is to sequence PCR products from the gene. Sometimes, it
might be difficult to determine the true polymorphisms when two peaks exist because of sequence
artifacts. When there is a single peak at one position, the SNP is homozygous. However, the SNP
is heterozygous if duple peaks are observed (Figure1.7) (Vignal et al., 2002). SNPs may be found
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within the coding, non-coding sequences of genes or between genes (known as intergenic regions)
(Miles et al., 2016). To identify SNPs, scientists compared the RJF genome sequence to partial
genome data of 4 chickens from 3 various types. These chickens are 1 White Leghorn: 2
commercial broilers: and 1 Silkie (Fleming, 2016). The identified SNPs help to create all the basis
for an SNP genotyping platform (Fulton, 2011). In protein-coding regions, a point mutation is a
heritable alteration in the genetic region in which a single nucleotide is replaced by another.
Synonymous, non-synonymous, and nonsense are three distinct types of mutations. To begin with,
even though synonymous mutations change the DNA sequences, they do not change the encoded
amino acids. Therefore, synonymous mutations are functionally silent and evolutionary neutral.
On the other hand, non-synonymous mutations change both DNA and protein sequences, and they
undergo natural selection. Similarly, nonsense mutations change the protein sequences because
they introduce a stop codon and produce incomplete protein products (Chu et al., 2019). The
majority of detected SNPs have little biological effect when they are located in the non-coding
region or exist in synonymous mutations. According to the DNA analysis of human beings, any
two individuals are 99.99% identical, whereas only 0.1% hold all the genetic variations (Crow,
2002). A transition: pyrimidine-pyrimidine (C ⇔ T) or purine-purine (A ⇔ G) exchanges, or a
transversion: pyrimidine-purine or purine-pyrimidine (G ⇔ C, G ⇔ T, A ⇔ C, A ⇔T) exchanges
are two significant mechanisms involved in the mutations. The mutations are considered to be
random if the ratio for transitions or transversions is 0.5 (Vignale et al., 2002).
SNP Chips
Genomic-based selections can be achieved if high-density SNP chips have been developed.
It enables genotyping to be done quickly, for a large number of animals, and at a minimal cost
(Wolc et al., 2016). The first chicken SNP chips contained only 3K SNPs, and this has been
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insufficient (Muir et al., 2008). In 2008, a grant proposal of approximately $5 million was
approved by the USDA for SNP genotyping of organisms with a genome sequence. This was
limited to only two animal species (cattle and chickens). The higher support was for the cattle SNP
chips. Consequently, the USDA grant for the chicken SNP chips was insufficient. Therefore,
several other commercial breeding companies, including Hendrix Genetics and Cobb-Vantress,
accepted and supported the initial proposal for this project. As a result of these monetary
contributions, the 60K SNP chip, which has been developed by Illumina, Inc., became private and
limited. The same company, Illumina, Inc., designed another SNP chip (42K SNPs). The second
chip was completely funded by other companies such as Lohmann Tierzucht, Hy-Line
International, and EW Group. Thus, the 42K SNP chip was not available to the public (Groenen
et al., 2011; Fulton, 2012; Kranis et al., 2013). These two medium-sized chips played a significant
role in genomic selection studies as well as they involved some genetic variations from layers and
broilers. In 2013, a high-density chip (600K SNPs) was developed with sponsorship from the
Roslin Institute and the BBSRC. This high-density chip was publicly available, and it contains
genetic variations from not only white and brown layer breeders but also broiler breeders (Kranis
et al., 2013). Surprisingly, despite the significant increase in high-density chips, the mediumdensity chips, which contain thousands of SNPs, are the most recent ones used for genomic
selections in poultry breeding. The SNPs used in the medium chips are carefully selected from the
high-density chip (600K). There are three main reasons for shifting back to medium-density chips.
First, due to technological advances, the price of medium-density chips has highly decreased, and
they are now equivalent to low-density chips. Second, we only need tens of thousands of SNPs
because this number can provide us with an accurate estimation of genomic breeding values (Ilska
et al., 2014). Third, the genomic prediction process is simplified using a medium-density chip
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rather than imputation from high to lower densities. As a result, medium-density chips will be an
excellent choice, soon, for a massive number of genomic selections in poultry (Wolc et al., 2004;
Habier et al., 2009).
Next-Generation Sequencing (NGS)
Next-generation sequencing (NGS) is a deep or highly parallel DNA sequencing method
that has revolutionized genomic research (Davey et al., 2011). Furthermore, NGS detects the
nucleotide order of the whole genome and targeted RNA. NGS is powerful since it can sequence
the entire human genome in a short period of time (it could be one day). In comparison, the
previous technology (Sanger sequencing) took over a decade to complete the final draft of the
human genome. NGS can be widely applied in clinical studies to improve patient care, and that
involves identifying mosaic mutations, studying rare somatic variations, and detecting novel
human microbiomes (Behjati et l., 2013; Swierniak et al., 2016; Malla et al., 2019). NGS has been
used to uncover new RNA variants and splicing regions or measure gene expression (Twine et al.,
2011). This technology examines the effect of epigenetic factors including DNA-protein
interactions and genome-DNA methylation (Movassagh et al., 2011). NGS is a cost-efficient
substitute for SNP genotyping methods, and it has the opportunity to improve both GWAS as well
as whole-genome selection (WGS) in chicken egg and meat production (Campbell et al., 2015).
This approach helps in detecting genetic variations across the whole chicken genome that are
linked to functional changes such as chromosome rearrangements, short INDELs, CNVs, and
SNPs (Baxter et al., 2011). Different methods such as microarrays, qRT-PCR, ChIP-seq, protein
analysis, siRNA, and in situ hybridization are used to eliminate or verify genetic variations once
NGS data has been stored and potential causative regions or genes have been identified (Schmid
et al., 2015). The high-density chip was successfully paired with WGS to detect the responsible
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gene for talpid2 mutation, and RNA-seq was performed to confirm the association between the
C2CD3 gene and this disorder (Chang et al., 2014). Likewise, WGS has been conducted at the
University of California for different developmental mutations involving limbless, eudiplopodia,
diplopodia-3, diplopodia-4, and stumpy (Schmid et al., 2015).
Copy Number Variations (CNVs)
A segment of genomic sequences, which range from 1000bp to million base pairs, can be
present in different quantities relative to the normal genome, and that is called copy number
variations (CNVs). Large-scale variations can be seen under a microscope. Therefore, they are
commonly detected and examined using microscopy during karyotyping (Feuk et al., 2006; Conrad
et al., 2010; Wang& Byers, 2014). Scientists, for a short period, ignored doing any research due
to the lack of appropriate studying tools. Nevertheless, during the last decade, advanced DNA
technology, including sequencing and microarray, has made it possible to identify CNVs in
different genomes. That results in increasing the CNV studies in different organisms, especially
humans (Carter, 2007). CNVs can be detected by comparing the DNA sequence of various cells
within the same organism or species. CNVs have resulted from sequence translocation, insertion,
inversion, deletion, substitution, or a combination of all these processes. An insertion results in the
addition of a genetic segment, whereas a deletion results in the loss of a genetic segment
(Mahmoud et al., 2019). Over the last few years, chicken CNVs have become a popular subject in
scientific research. Chicken CNVs research is motivated by a variety of interests from both a basic
biological point of view and a poultry science perspective (Kanginakudru et al., 2008; Griffin et
al., 2008). Array comparative genomic hybridization (aCGH), which was the first effective method
for scanning the genome for CNVs, was used to identify CNVs in chickens, humans, and other
species (Pinkel & Albertson, 2005; Bertone et al., 2006; Fiegler et al., 2006). Moreover, CNVs
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were detected using SNP arrays. Even though the main purpose of designing SNP arrays was SNP
genotyping, it is possible to detect CNVs using this technique due to the formation of abnormal
hybridization. This occurs when both a CNV region and an SNP probe are in the same position
(Colella et al., 2007; Wang et al., 2007). Using SNP arrays in identifying CNVs makes a difference
in the combination of GWAS with SNP arrays. This method is particularly popular in human
studies (Jakobsson et al., 2008; Wheeler et al., 2013). Several studies were conducted to detect
CNVs in animals involving chickens (Jia et al., 2013). In this review, we will discuss several
examples related to the identification of CNVs across the chicken genome using GWAS analysis.
Griffin et al. reported that there are 12 CNVs found in RJF/domestic chickens. The size of CNVs
was estimated to be 90kb and 127kb, which were distributed on micro and macro- chromosomes
(2008). Other studies have focused on copy number variation regions (CNVRs) which have been
defined as the sum of overlapping CNVs found in two various specimens (Upadhyay et al., 2017).
The CNVRs in chickens account for 8.3% of the genome (Wang& Byers, 2014). Crooijmans et
al. identified the largest CNVs in commercial line/ experimental line. The total number of CNVs
was 3,154, 1556 of which were CNVRs. The largest CNVs were observed in chromosome Z, with
an average size of 46.3kb (2013). A study found a relationship between CNVs and Marek’s disease
(MD) (Xu et al., 2017). MD, which is caused by alphaherpesvirus, is a major issue in the poultry
industry (Engel et al., 2012). In four chicken lines, a total of 45 CNVs have been identified, 28 of
them play a significant role in cell proliferation and immune response, and two CNVs are
responsible for MD resistance. This new finding may result in more effective techniques for
genetic manipulation of disease resistance in chickens (Luo et al., 2013). The CNVs can impact
phenotypes because they have the potential to alter the function of the proteins if they are
implicated in protein-coding. In addition, the CNVs affect gene expression if they are linked to the
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regulatory regions of the gene. The CNVs might influence up to 500Mb away (Henrichsen et al.,
2009). There are several traits associated with CNVs in chickens, such as dark brown plumage
color, late feathering, dermal hyperpigmentation, and pea-comb (Elferink et al., 2008; Wright et
al., 2009; Dorshorst et al., 2010; Gunnarsson et al., 2011).
Epigenetics in Poultry
several economically significant features in animal production show a phenotypic variation
because of environmental and polygenic factors. Although several QTLs for agronomic traits have
been detected, the fundamental genes for most of these traits are still ambiguous. GWAS revealed
that genetic variation is the major cause of diversity in complex traits (Manolio et al., 2009; Frésard
et al., 2013). According to genetic and epidemiological analysis in both animals and humans,
epigenetic marks can be passed down across generations and impact the phenotypes of offspring
(Jablonka et al., 2009). Epigenetics has been defined as the phenotypic changes without alterations
in DNA sequence, and that are passed down from generation to generation (Ho et al., 2010).
According to Russo et al., epigenetics is “the study of mitotically and/or meiotically heritable
changes in gene function that cannot be explained by changes in the DNA sequence” (1996). Bird
stated that; “epigenetics is the structural adaptation of chromosomal regions to register, signal or
perpetuate altered activity states” (2007). The epigenetic mechanisms are essential gene regulators
which play a significant role in establishing the heritable modifications in gene expression without
changing the nucleotide sequences (Rivera et al., 2013). These mechanisms involve DNA
methylation, histone modification, chromatin remodeling, noncoding regulatory RNA (lncRNA,
miRNA, snoRNA), and DNA packaging. Moreover, epigenetic marks are involved in determining
active transcription or gene silencing patterns, as well as contribute to tissue-specific gene
expression (Youngson et al., 2008; Jin et al., 2011; Mazzio et al.; Feil, 2012; Jeltsch et al., 2016).
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Epigenetics marks can be passed from cell to cell during pedigree development, and they can
influence individual phenotypes if they receive them at an early age. Epigenetic marks can
influence the phenotypes of future generations through intergenerational effects caused by
epigenetic modifications obtained during embryogenesis or via epigenetic marks passed down over
generations through gametes (Jablonka et al., 2009; Daxinger et al., 2012). The expansion rate in
publications and research on epigenetics has considerably grown up in different organisms because
of the rapid advancement of NGS technology and the sharp decline in costs. Unfortunately, there
is little research on the relationship between epigenetic mechanisms and commercially significant
traits in chickens. It is still a puzzle how epigenetics impacts gene expression (how much, when,
and where) in chickens. Nevertheless, there is an expectation of having more epigenomic data
published in the near future, which will dramatically increase our insight into the genomephenome interactions (Frésard et al., 2013).
The Effect of Genetic Selection on Broiler Welfare
Intensive genetic selection for commercially significant traits such as growth rate, body
weight, and feed efficiency have increased production and efficiency in poultry breeding
companies (Havenstein et al., 1994; Hunton, 2006; Elfick, 2012; Tavárez et al., 2016;). In today’s
world, breeding programs with extremely precise estimated breeding values are achievable due to
the availability of accurate technologies and a better understanding of how gene networks are
connected to production traits. Therefore, broiler production grew by more than 400% between
1957 to 2005 despite a 50% decrease in feed conversion (Barton, 1994; Zuidhof et al., 2014). The
production rate of livestock has dramatically increased because of genetic selection. Nevertheless,
in addition to a beneficial increase in production, species that have been chosen for high productive
efficiency appear to be more susceptible to immunological, behavioral, and physiological
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abnormalities. There are more than 100 articles that have been published associated with
unfavorable (cor)related consequences of intensive genetic selection for high production efficiency
in pigs, broilers, and dairy cattle in terms of reproductive, health, and metabolic features (Rauw et
al., 1998). The genetic selection might cause animals to lose their homeostasis, which leads to
several diseases and, as a result, poor animal welfare. In this review, we will be focusing on the
genetic selection in poultry and discuss several examples of unfavorable side effects of extensive
genetic selection for high production efficiency. To begin with, genetic selections to increase body
weight in turkey result in having a considerably heavy male, which prevents natural breeding
(Rauw et al., 1998). If natural breeding occurs, it causes damage to the hens’ backs (Hunton, 1984).
In addition, increased body weight reduces fertility in broiler breeders (Dunnington, 1990; Liu et
al., 1994). Furthermore, genetic selection to increase body weight has changed the growth style in
broilers (Anthony et al., 1991). Chickens with a high body weight developed faster, the rate of
lipolysis decreased, and that resulted in increased fat deposition (Chambers et al., 1981; Barbato
et al., 1984; Calabotta et al., 1985). Sinsigalli et al. (1987) suggested that increased fat deposition
in broilers is linked to elevated insulin and glucagon level in the blood, as well as insulin resistance.
In broiler breeders, excessive genetic selection for a high body weight produces a large number of
eggs. However, most of the eggs are defective (e.g., soft-shelled, shell-less, extra calcified, double
yolk) (Van Middelkoop et al., 1976). Dunnington and Siegel (1996) indicated that the major cause
of defective eggs is a lack of synchronization between ovulation and egg packaging. Moreover,
genetic selection for body weight may evolve a poor immunological performance. For instance,
when the broilers with higher body weight are challenged by lamb erythrocytes, they demonstrate
fewer antibody responses (Miller et al., 1992). By comparing the commercial1991 broiler lines to
random-bred 1957 baselines, a higher mortality rate was observed in commercial broilers at 42
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days of age due to leg problems and ascites. Furthermore, the commercial broiler lines can be
affected more by tibial dyschondroplasia (~47.5%) than random-bred baseline (2.2%) (Havenstein
et al., 1994). It was reported that the incidence of dyschondroplasia was 28% in roosters selected
for a high body weight compared to 3% in those selected for a low conversion rate of feed. In
addition, broilers with high body weight have shown a greater risk of mortality (~7.4%) than those
with a low conversion rate of feed (2%), and the major cause of mortality was heart and circulation
disorders and infectious diseases (Leenstra, 1993). Broilers selected for a high body weight showed
several skeletal problems including long bone distortions, tibial dyschondroplasia, rickets,
chondrodystrophy, and other infectious diseases that induce skeletal problems such as retrovirus,
Mycoplasma synovia, and Staphylococcus aureus. According to estimates, 3.2 percent of broiler
losses were attributable to skeletal anomalies in terms of condemnation, culling, and death. That
negatively impacts the economy because the poultry industry lost $0.16/broiler or $120
million/year (Cook, 2000). Moreover, skeletal maturity and strength are regulated by several
factors involving gender, growth aging, toxins antinutrient, nutrition, disease, physical loading,
endocrine, and genetic factors (Rath et al., 2000). Intensive genetic selection for rapid growth
produces broilers that are susceptible to heart-related problems such as chronic heart failure
(ascites, hypoxia) and acute heart failure (SDS) (Olkowski et al., 1998; Korte et al., 1999;
Olkowski, 2007). My research has focused on one of the most significant metabolic conditions,
that being ascites. Ascites or pulmonary hypertension (PH) has been defined as the accumulation
of fluid in the abdominal cavity; a condition referred to as “water belly” (Figure1.8). The goal of
this dissertation is to study the genetics of PH in broilers as well as to identify biomarkers relevant
to the disease.
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The Function of Heart and Lung
The avian heart is divided into four chambers: left and right ventricles, as well as left and
right atria. The blood is passed from the right ventricle to the pulmonary artery, which then
transports it to the lungs for oxygenation. Then, the oxygen-rich blood is pumped by the left
ventricle for systemic circulation. There are two major differences between left and right
ventricles. First, the right ventricle functions at a lower pressure, whereas the left ventricle
functions at a higher pressure. Second, the muscle mass in the left ventricle is higher than in the
right ventricle (Olkowski et al., 1998; Tekeli et al., 2014). The left and right ventricles maintain
distinct systolic pressures, which cause the size differences. Therefore, more systolic pressures can
be produced by the left ventricle under normal circumstances (Tarrant, 2016). When a broiler chick
hatches, it weighs 40g and can grow to 4000g in two months. If we grow at the same rate, the
weight of infants would be 300kg in 8 weeks. This massive growth cannot be sustained if there is
no equal increase in the function of both the heart and lungs. This includes increasing the cardiac
output after chick hatches. The range of cardiac output should be from 480 mL/hour for a 40-g
chick to 48L/hour for a 4-kg broiler ((Wideman et al., 2013). The circulating blood return to the
heart for oxygenation. The cardiac pulmonary system initiates once the deoxygenated blood reenters the heart via the right atrium. The right ventricle takes the deoxygenated blood and pumps
it to the lung via the pulmonary artery. In a healthy bird, the pulmonary artery pressure is
approximately 20mmHg (Chapman & Wideman, 2001; Tarrant, 2016).
Ascites or Pulmonary Hypertension Syndrome (PHS) in Chickens
Ascites syndrome, pulmonary hypertension syndrome (PHS), or pulmonary arterial
hypertension (PAH) in modern poultry is the negative result of intensive genetic selection for high
body weight. PHS was identified in the 1950s as a serious issue that affected broilers under
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abnormal conditions such as cold weather, high ambient altitude, and hypoxia (Smith et al., 1954).
In the 1980s, the PHS rate was highly increased in broilers due to the fast-growing rate and feed
conversion. PHS is mainly caused by a number of processes, but all of them lead to pulmonary
hypertension and right ventricular failure. As a result, the level of oxygen in other tissues is low
due to the high demand for oxygen during fast growth. PHS has become a popular subject and has
been thoroughly tested (Julian, 1993; Owen et al., 1994; Scheele, 1996). Pavlidis et al. (2007)
reported that the mortality of ascites in broilers had reached 30%. Ascites is responsible for 8% of
the 361million broilers' death annually. Ascites have negatively impacted the economy in the
United States because the cost of ascites was estimated to be $100 million each year. Recently,
PHS is no longer a problem due to intensive genetic selections against this disease that have been
conducted by commercial breeding companies. Modern broilers can acquire the desired weight in
60% less than the old broilers. However, the capacity of cardiac and pulmonary in both old and
modern broilers are the same. As a result, the cardiopulmonary system in both broilers is forced to
work at or near its physiological limitation (Baghbanzadeh, & Decuypere, 2008). The pulmonary
capacity does not always provide enough oxygen to support rapid growth. That makes it more
difficult to manage the energy balance in severe circumstances, such as cold weather or high
altitude. (Luger et al., 2003). Schmidt et al. (2003) conducted a study in modern and 1950s
unselected broilers to compare the differential growth of breast and heart. At five weeks of age,
the breast muscle in the old broilers accounted for 9% of total body weight, while the breast muscle
in the modern broilers accounted for 18% of total body weight. Conversely, the heart size in
modern broilers reduced at 14 days of age, indicating that genetic selection for rapid growth in
breast muscle resulted in a heart muscle reduction. That might cause cardiovascular complications
since the small heart in the modern broilers has to work to maintain the rapid growth of the broilers
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(Konarzewski et al., 2000). Various factors might cause PHS. To begin with, primary factors such
as chemicals, heat, cold, and certain nutrients might decrease vasodilation due to a higher
metabolic rate, or these factors might cause pulmonary hypertension that triggers ascites in broilers
due to the higher resistance to pulmonary blood flow by: (i) a reduction in the pulmonary vascular
capacity; or (ii) the rigidity of red blood cells or higher blood viscosity. Secondary factors,
including excessive sodium ratio in water or feed, might cause not only increased blood flow but
also an increase in the resistance to pulmonary blood flow (Julian, 2000). Other studies proved
that germ-negative bacteria such as Salmonella typhimurium and Escherichia coli could induce
PHS in meat-type chickens. That occurs because the germ-negative bacteria contain
lipopolysaccharide (LP) in their outer membrane, and respiratory exposure to this type of bacteria
increases the incidence of PHS. LP induces pulmonary hypertension by inducing pulmonary
vasoconstriction (Tottori et al., 1997; Chapman et al., 2005).
The Physiology and Etiology of PHS
PHS is a multifactorial disorder that is influenced by genetic, environmental, physiological,
and nutritional factors. That triggers several subsequent complications, which end with ascites
(Baghbanzadeh, & Decuypere, 2008). PHS in broilers is linked to right ventricular hypertrophy
(RVH) and pulmonary hypertension that stimulates by various factors such as increased muscle
mass, air quality, cold or heat, and elevated sodium rate. There are significant characteristics of
broilers or meat-type chickens which make them susceptible to PHS. The broilers’ lungs are small,
firm, and anchored in the thoracic cavity. Both respiratory capillaries and blood capillaries form a
rigid system. The physiology and morphology of the respiratory system in broilers are crucial in
increasing the incidence of PHS. The small body size, heavy and large breast muscle, and high
pressure on alveoli play a significant role in triggering PHS (Julian, 1993). Broilers with PHS can
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be characterized by the presence of ascitic fluid in the abdominal cavity, the congestion of central
venous, liver cirrhosis, and right-sided cardiac failure. PHS is developed in broilers during their
fast growth because of the high oxygen demand. This might stimulate cardiac output, which
increases the pressure in both lungs and the right ventricle (RV). The RVH gets thicker to face the
sudden higher pressure, and that leads to high pressure in pulmonary capillaries and arteries
(Figure1.9). The right atrioventricular (AV) valve gets thicker, too. When the right AV fails, both
cardiac output and hypertension decrease. However, the pressure in the vena cava, right atrium,
portal vein, and sinus venous increase (Chapman and Wideman, 2001). Others suggested that
increasing the blood flow through the pulmonary vasculatures inhibits red blood cells from staying
for a long time on the respiratory surface to get enough oxygen, resulting in hypoxemia (Olkowski
et al., 1998). Elevated blood pressure in the veins causes portal hypertension in the liver, which
induces plasma leakage into the peritoneal space. PHS is recorded only if there is plasma
accumulation in the abdominal cavity (Wideman and French, 2000).
Methods for inducing PHS
The genetic foundations of disorders like PHS have long been studied using broilers.
Broilers are not the only domestic animals that develop PHS, but they are more prone to develop
this disease. This makes broilers a good model for PHS research. To study the PHS in broilers, the
targeted population must first be challenged so it develops PHS. There are different methods used
in literature to induce PHS. Using a pulmonary artery clamp, Wideman and Kirby (1995a) set off
a number of pathophysiological progressions to induce PHS in broilers. The incidence of PHS
among broilers was raised by the surgical clamp, and the ranges were between 68% to 90%. On
the other hand, the control group (broilers without a surgical clamp) showed a lower PHS incident
(0 % to 12%). Another study from the same research group proved that injecting the intravenous
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broilers with microparticles induced PHS. This occurred due to microparticles occluding a small
part of the pulmonary arteriole, increasing the cardiac output, followed by hypoxia development
(Wideman and Erf, 2002). Environmental methods found to be involved in the development of
PHS such as cold stress (Lubritz & McPherson, 1994; Balog et al., 2003; Ipek& Sahan, 2006),
dietary supplementation (Villar-Patiño et al., 2002; Wang et al., 2013; Fathi, 2016), lighting (AlMasri et al., 2012), and high altitude (Özkan et al., 2010). As mentioned previously, PHS was
identified in the 1950s among broilers grown at high ambient altitudes (Smith et al., 1954). At the
University of Arkansas, Dr. Anthony and his group developed a hypobaric chamber that works
under a partial vacuum to reduce oxygen partial pressure and stimulates the high altitude
(Figure1.10). The hypobaric chamber is an advanced and beneficial method since it develops
different populations with PHS for several generations (Owen et al., 1990; Tellez et al., 2005; Dey
et al., 2018; Balog et al., 2000). In this dissertation, the hypobaric chamber is the only method used
to induce PHS in broilers.
Divergent Selection for Developing Ascites Research Lines
Divergent selection is a powerful and excellent method used to generate different ascites
experimental lines (Balog et al., 2003). In 1994, Dr.Anthony and his colleagues (at the University
of Arkansas, Department of Poultry Science) initiated the selection program for ascites
development. Essentially, chickens from a commercial elite line were raised in a hypobaric
chamber to mimic the high altitude (9000ft above sea level). The hypobaric chamber was provided
with a partial vacuum to decrease the partial oxygen pressure and induce the PHS. Susceptible to
PHS (SUS line) and resistant to PHS (RES line) are the main genetic lines that were developed for
further studies (Balog and Anthony, 2000; Tellez et al., 2005; Pavlidis et al., 2007). In 1995, these
groups, which are the main population, were moved to the poultry research building at the
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University of Arkansas. These birds were raised for six weeks in a hypobaric chamber. Meanwhile,
several significant data were collected, such as mortality rate, body weight, the accumulation of
plasma in the abdominal cavity or the pericardium, heart and liver shape, and the major cause of
death. They recorded information about dead birds, such as gender, the date of death, and body
weight. At the end of the experiment (usually six weeks), all the surviving birds were terminated,
then they were necropsied to evaluate birds for PHS and remove the important organs (liver, heart,
spleen) for further examination. Birds were classified into SUS or RES based on the collected
information, including the ratio of the right ventricle (RV) to the total ventricle (TV) and the
presence of ascetic fluid in the peritoneal cavity. Series breeding was conducted using 24 Sire
families (three females and one male per Sire) to reproduce the targeted line with several
generations as well as generate siblings to collect mortality rates for further selection.
Nevertheless, both SUS and RES lines were developed after a few generations of divergent
selection (Figure 1.11). In addition to the previous two lines, the relaxed unselected (REL) line
was randomly mated to serve as (the original population or the control group) and showed 75.3%
of PHS incidence. However, it was obvious that the incidence of PHS in the SUS line was the
highest (95.1%), while the incidence of PHs in the RES was the lowest (7.1%) (Figure1.12) (Balog,
2003; Pavlidis et al., 2007; Wideman et al., 2013).
Genetic Markers for PHS
The heritability rate, mortality, and incidence of PHS are three major differences between
the three lines (SUS, RES, REL) (Pavlidis et al., 2007; Krishnamoorthy et al., 2014). Nowadays,
the chicken genome has been extensively studied to identify the molecular basis of a specific
phenotype (Theron et al., 2001). Therefore, it is very significant to determine the molecular
modifications that occurred in these lines as a result of selection. Scientists started by performing
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the candidate gene approach. A mutation in the bone morphogenetic protein receptor-II (BMPR 2)
gene is one of the major causes of PHS in humans (Deng et al., 2000; Rudarakanchana et al., 2002;
Morisaki et al., 2004). The PHS in humans is physiologically and genetically similar to this in
broilers (Druyan and Moschandreou, 2012). Therefore, a study has been done by Cisar et al. to
investigate whether mutations in the BMPR 2 gene play a significant role in initiating PHS in
broilers or not. By comparing the RNA sequences of both ascitic and non-ascitic commercial
broiler lines to those of White Leghorn chicken, there were 14 SNPs detected in the BMPR2 gene
of the commercial line, and there were no mutations associated with PHS. In addition, in the coding
region of the gene, there were 12 synonymous substitution SNPs. However, these SNPs did not
change the protein sequence. Moreover, the BMPR2 gene expression was measured by RT-qPCR,
and the results revealed that the expression level of the gene is the same in the two groups (2003).
A second generation (F2) was generated through double reciprocal crosses of RES and SUS lines.
Then, A genome-wide SNP was performed to find chromosomal regions associated with PHS
susceptibility. The statistical analysis illustrated a relationship between a region on chromes 9 (12
to 13Mbp) and PHS phenotype in both experimental lines (RES and SUS) and the commercial
line. The susceptibility to PHS was gender-specific because females were more affected than
males. Several candidate genes were involved in this region, such as urotensin 2 domain (UTS2D),
an angiotensin II type 1 receptor (AGTR1), and Serotonin Receptor/Transporter type 2B (5HT2B)
(Burks et al., 2011Wideman et al., 2013; Krishnamoorthy et al., 2014). Moreover, other studies
identified several regions associated with the PHS phenotype that are distributed across the
genome. These regions are seven regions on chromosome 4, three regions on chromosome 9 (13.514.8Mbp, 15.5-16.3Mbp), and one region on chromosome 27 (2.0-2.3Mbp) (Wideman et al.,
2013). In addition to the previous candidate genes identified in chromosome 9,
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angiotensinogen cleaving enzyme (ACE) is a candidate gene found to be related to ascites
susceptibility (Wideman et al., 2013). The candidate genes UTS2D, AGTR1, and ACE were found
to be correlated to some aspects of hypoxia or high blood pressure in humans or mice (Watanabe
et al., 2006; Djordjevic and Goerlach, 2007; MacLean, 2007; Chung et al., 2009; Simonneau et
al., 2014). Another study showed an association between regions on chromosomes 2, 4, 5,6, 8, 10,
27, and 28 and PHS (Rabie et al., 2005). In our lab, Dey et al. performed a GWAS on the REL line
and commercial elite line to identify regions associated with PHS susceptibility or resistance. The
statistical analysis illustrated a significant relationship between chromosome 9 (11.8 to 13.6Mbp)
and PHS. Within this region, two candidate genes (UTS2D and AGTR1) were identified earlier
and confirmed by Dey et al. to be associated with PHS (2017). Another subsequent GWAS was
conducted in our lab on REL at 16 and 18 generations using a 60K SNP chip. Two significant
regions on chromosome Z (60Mbp) and chromosome 2 (70Mbp) were found to be relevant to PHS
incidence (Tarrant). Myocyte enhancer factor 2C (MEF2c) gene is a candidate gene located inside
the Z chromosomal region and is responsible for PHS resistance in females. On the other hand, the
melanocortin-4-receptor (MC4R) gene and Cadherin 6 (CDH6) are two candidate genes identified
within the 2 chromosomal regions and associated with PHS resistance in males (Tarrant et al.,
2017). However, these two regions were not effective in MAS breeding. Therefore, our research
group conducted WGR in the REL line and identified 31 regions associated with the PHS trait
(Figure1.14). Two of these regions were thoroughly studied by Dey et al. (2018) and Parveen et
al. (2020). As a result, the carboxypeptidase Q (CPQ) gene on chromosome 2 (127.62 to 127.75
Mbp) and leucine-rich repeat transmembrane neuronal 4 (LRRTM4) gene on chromosome 22
(3.80 to 3.90Mbp) related to PHS resistance in male broilers. These two genes were the first
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identified through GWAS and WGR that was demonstrated to be associated with ascites through
additional genotyping.
In humans GWAS, CPQ gene, or plasma glutamate carboxypeptidase (PGCP) gene was
found to be associated with heart rate, hypertension, and blood pressure. Both CPQ and LRRTM4
have not been identified before as markers for PHS resistance in male broilers. Male broilers are
prone to PHS due to their larger body weight and increase oxygen requirement for rapid growth.
However, according to GWAS results, male and female broilers showed a higher SNP frequency
for CPQ and LRRTM4. There was one attempt of using these two genes in MAS, and they were
validated by Lee et al. (manuscript in review).
SYNOPSIS
The major focus of this dissertation is on the genetic, proteomic, and metabolomic studies
of pulmonary hypertension in fast-growing broilers. The first study (chapter 2) emphasizes
measuring the CPQ gene expression level among eight tissues (heart, liver, kidney, thigh, breast,
spleen, lung, thymus) from unchallenged, six-week-old REL line birds from both genders with
specific genotypes (homozygous reference, heterozygous, homozygous non-reference). Moreover,
further analysis was performed on previous next-generation sequencing (NGS) data, which show
a large chromosomal deletion (~125Kbp) affecting the CPQ gene. The deletion is spanning from
intron 4 to ~ 40 kbp downstream of exon 8. The aim of the second chapter (chapter 3) was to
identify proteins, fatty acids, lipids, and small molecules in REL line birds “non-challenge with no
ascites (NC-NA), challenge with no ascites (C-NA), challenge with ascites (CA)”. Various mass
spectrometry analysis (tandem mass spectrometry “LC-MS)/MS”, gas chromatography-mass
spectrometry “GC-MS”, liquid chromatography-tandem mass spectrometry “LC-MS”) was done
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to determine the proteomic and metabolomic changes concerning hypobaric challenge and ascites.
Finally, chapter 4 summarizes the results and highlights the major conclusion of this dissertation.

35

TABLES AND FIGURES

Figure 1. 1. Broilers Production in the Top States (GA, AR, AL) from 1991to 2013 (Bishop
et al., 2015).
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Figure 1. 2.Broilers Performance Trends. Broiler performance has improved dramatically
as a result of research and innovation (Bishop et al., 2015).
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Figure 1. 3. The Meat Consumption (Chickens, Beef, and Pork) in the USA (Larsen, 2012).
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Figure 1. 4.Breeding Schemes Used in Modern Broiler Industries (Tarrant, 2016).
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Figure 1. 5.Line Crossing Observed at Each Level of in Poultry Breeding Pyramid
(Tarrant, 2016).
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Figure 1. 6.The Karyotype of Chicken. The chicken karyotype is made up of 39
chromosome pairs (Castillo et al., 2010).
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Figure 1. 7.Sanger Sequencing of PCR Product. SNPs can be identified by sequence alignment.
Box 1 represented the first allele for three different genotypes (homozygous AA, heterozygous
AG, and homozygous GG). Box 2 represented the second allele (homozygous CC, heterozygous
CT, and homozygous CC) (Vignal et al., 2002).
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Figure 1. 8.Ascites Symptoms in Broilers. One of the most significant symptoms is the
accumulation of fluid in the abdominal cavity (Dey, 2017).
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Figure 1. 9.A Cross-Sectional of Two Ventricles. (A) a normal heart; (B) an ascitic heart with
ventricular dilation (Olkowski et al.,2001)
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Figure 1. 10.A Paradigm of a Hypobaric Chamber used at the University of
Arkansas to induce Ascites in Broilers.
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Figure 1. 11.The Development of Three Major Lines (SUS, RES, and REL) from the
Commercial Pedigree Line (Pavlidis et al., 2007).
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Figure 1. 12.The Three Major Lines (SUS, RES, and REL) with Multiple Generations are
Differently Affected by Ascites (Pavlidis et al., 2007).
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Figure 1. 13.The Cumulative Ascites Mortality Obtained from Three Broiler Lines (SUS,
RES, and REL) at Generation 14 (Wideman et al., 2013).
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Figure 1. 14.Data from Whole Genome Resequencing in REL Shows 31 Regions Associated
with Ascites (Parveen et al., 2020).
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CHAPTER 2
A 125 Kilobase Deletion Affecting the Carboxy Peptidase Q Gene in Broilers
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ABSTRACT
Ascites syndrome is a pathophysiological condition resulting from unmet body demand for
oxygen in fast-growing broilers. The high demand for oxygen increases the pressure within the
pulmonary circulation, leading to the accumulation of fluid in the abdominal cavity and increasing
the mortality rate. Previously we used whole-genome resequencing to identify 28 gene regions
related to ascites. One of these regions is a 127 kbp region on chromosome 2 encompassing the 3’
end of the Carboxypeptidase Q (CPQ) gene. The CPQ gene; also known as Plasma Glutamate
Carboxypeptidase, encodes a metallopeptidase that plays a significant role in the cleavage of
dipeptides into amino acids. Gene expression assays measured the CPQ gene expression among
different tissues (heart, liver, kidney, thigh, breast, spleen, lung, and thymus) using the
housekeeping gene TATA-box binding protein (TBP) as reference. These results indicated that the
CPQ gene is highly expressed in the liver (p-value=0.008) in chickens. Based on reading depth
analysis of our next-generation sequence data, some broilers carry a CPQ gene deletion spanning
from intron 4 to ~40 kbp downstream of exon 8. We developed PCR primers that span the deleted
region allowing us to fine map the exact limits of the deletion, which appears to have resulted from
the recombination of two CR1 repeats. We used exonuclease PCR assays to genotype for relative
levels of exon 2 and 8 to quantify the prevalence of the deletion in our REL ascites research line;
an unselected closed population derived from a commercial broiler elite line from the 1990s.
Whether this deletion exists in other populations and the relationship of the deletion to ascites
phenotype will need to be determined.
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INTRODUCTION
Pulmonary hypertension syndrome (PHS), also known as ascites syndrome, is a metabolic
disease affecting fast-growing broilers due to increased meat yield and rapid growth (Julian, 1993;
Khajali & Wideman, 2016). The PHS cause increasing blood pressure which elicits several
pathophysiological progressions involving elevated oxygen requirement, central venous and right
ventricle congestion, heart and liver failure, and the accumulation of ascitic fluid in the abdomen
to form a water belly, and results in birds’ death (Wideman, 2000). The PHS is attributed to a
reduction in cardiac output (Wideman & Kirby, 1995). However, the major cause of PHS is still
ambiguous till now, which makes it idiopathic. Therefore, broilers are an excellent model for
idiopathic pulmonary arterial hypertension in humans (Wideman & Hamal, 2011). A higher body
rate requires more oxygen, which has been pronounced in modern male broilers. Thus, males are
prone to develop ascites relative to females (Baghbanzadeh & Decuypere, 2008; Closter, 2014).
To reduce the incidence of ascites in the United States, several environmental and nutritional
factors have been controlled involving temperature adjustment, lighting reduction, nutritional
control, and ventilation (Aftab & Khan, 2005; Fairchild & Lacy, 2006; Baghbanzadeh &
Decuypere, 2008). Nevertheless, the worldwide economic loss has been estimated to be $100
million annually (Tarrant et al., 2017). Genetic factors are associated with PHS due to the high
heritability of ascites-related traits, including ventricular hypertrophy (Pakdel, 2004). Thus,
identifying ascites-related quantitative trait loci (QTL) could assist reduce the economic loss due
to the genetic selection against susceptibility (Parveen et al., 2020).
Currently, several genetic markers have been developed for marker-assisted selection
(MAS) (De Greef et al., 2001; Pakdel et al., 2005; Li et al., 2015). In our lab, several single
nucleotide polymorphisms (SNPs) based genome-wide association studies (GWAS) were
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performed to identify a possible genetic marker associated with ascites and used for MAS
(Krishnamoorthy et al., 2014; Dey et al., 2017; Tarrant et al., 2017). Several potential regions were
identified on chromosomes 1, 2, 4, 9, and Z. However, these regions were not used for MAS
because they showed a minor association with ascites. A whole-genome-resequencing (WGR) was
performed by Alia Parveen, a previous Ph.D. student in our lab, to determine the associated regions
for ascites resistance or susceptibility on both chromosomes 2 and 9 (Parveen et al., 2020). A new
region (127.65-127.75Mbp) was identified on chromosome 2, which spans a large part of the gene
known as the Carboxypeptidase Q (CPQ) or plasma glutamate carboxypeptidase (PGCP) gene.
This gene was found to be responsible for high blood pressure or hypertension in humans and
associated with ascites resistance in broilers. Shatovisha Dey determined that the CPQ gene is
highly expressed in three major ascitic organs (heart, lung, liver) in the different genotypes (Dey
et al., 2018). In this study, we expanded the gene expression study by looking at the CPQ gene
expression in five additional tissues. Additionally, we used Next-generation-sequencing (NGS)
data and PCR to investigate a possible large deletion affecting the CPQ gene, which had been
initially suggested by Dr. Giri Athrey of Texas A&M (personal communication). The deletion
could affect ascites resistance or susceptibility.

MATERIALS AND METHODS
Animals Resources
All the animal processes (breeding, hatching, and growing out) were done at the University
of Arkansas Poultry Research farm. An approval from the University of Arkansas Institutional
Care and Use Committee was obtained to do this work (the protocol numbers were 15039, 15040,
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21087, and 21088). All the birds and DNAs that have been used in this study are from the relaxed
unselected (REL) line at the 18th generation (Pavlidis et al., 2007; Dey et al., 2018).
Genomic Data
All the genome positions correspond to those in the March 2018 assembly of the
Gallus_gallus-6 genome (The accession ID: GCF_000002315.5). The required genomic
sequences for particular genes or chromosomal regions were obtained from either the NCBI
(National Center for Biotechnology Information (nih.gov)) or the UCSC genome browser (UCSC
Genome Browser Home).
DNA Extraction from Blood
A total volume (10ul) of the blood samples was collected from the birds at four days of age
through towing venipuncture. DNA extraction was done using a rapid protocol as described
previously and stored at -20℃ (Bailes et al., 2007).
DNA Extraction from Tissues
The frozen tissues, which were stored in RNA later (SIGMA; St.Louis, MO) at -20℃, were
cut into small pieces (50-100mg) and rinsed with 1X cold phosphate buffer saline (PBS). Then,
the tissues were homogenized in 1ml TE buffer (10 mM Tris-HCl, 1 mM Na2 EDTA pH 7.5) using
a Bullet Blender homogenizer (Next Advance, Inc., Averill Park, NY). Autoclaved beads were
used to homogenize the tissues, and bead size was adjusted depending on the particular tissue.
Sodium dodecyl sulfate (SDS) was added to a final concentration of 0.5%, and the samples were
incubated for 10 minutes at 50℃. RNAse was added to a final concentration of 200ug/ml, and the
samples were incubated for 30 minutes at 37℃. A solution of 250mM of EDTA was added to the
samples to bring to 10mM and then incubated for 10 minutes at 50℃. The solution was made
100ug/ml for Pronase E and incubated overnight at 37℃. The DNA was extracted three times with
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50:50 phenol: chloroform and two times with chloroform. Sodium acetate (3 M, pH 5.2) was added
to 0.3 M, followed by DNA precipitation using 95% alcohol. The samples were centrifuged at 4℃
for 20 minutes at 12000 x g to produce a DNA pellet. The DNA pellet was rinsed with 70% alcohol,
dried, and dissolved in Te (10 mM Tris-HCl 0.1 mM EDTA pH 7.5). The DNA was then evaluated
for quantity using fluorimetry using Hoechst 33258 (GLOMAX Multi Jr, Promega 91 Corp.,
Madison, WI) and optical purity, A260/280 (NanoVue, GE Healthcare Biosciences, MA, USA).
Designing Primers, Probes, and PCR Sequencing
The sequence of the DNA for the Jungle Fowl CPQ gene on Gallus_gallus-6 genome Chr
2 at 126,884,501-127,048,754 was downloaded from the UCSC genome browser. Manipulation
and annotation of the CPQ gene sequences were done using the SeqBuilder software (DNASTAR
Lasergene Suite 16). Design of PCR primers and probes utilized Primer3 (version 0.4.0;
http://bioinfo.ut.ee/primer3-0.4.0/primer3/) with adjusting general primers parameters to primer
size (18-24bp), G/C content (40-60%), and annealing temperature (55-65℃). Primer and probe
uniqueness was checked by BLAT searches in the UCSC genome browser. Primers and probes
were synthesized by Integrated DNA Technologies (IDT; Coralville, IA, USA). Primers and
probes are listed in Table 2.1. PCR was performed in a T-100 thermal cycler (BioRad Laboratories,
Hercules, CA). The total PCR volume was 20ul, which contained 1X Taq Buffer (1mM MgCl2,
30ug/ml BSA, 50mMTris-Cl pH8.3), 0.5uM of both forward and reverse primers, 0.2mM dNTPs,
4U of Taq polymerase, and 2ul with an approximate concentration of 100ng/ul chicken DNAs.
The PCR protocol was; an initial denaturation of 90℃ for 30 seconds, 40 cycles of 90℃ for 15
seconds, the primer specific- annealing for 30 seconds (Table 2.1), 72℃ for 1 minute, and a final
extension of 72 ℃ for 3 minutes, followed by infinity at 4℃. The PCR protocol was optimized
based on each primer pair to amplify a specific region on the mRNA or CPQ gene. The positive
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control consisted of the master mix plus 2ul of white leghorn (WL) DNA, while the negative
control did not contain DNA. To evaluate the quality, 5 ul of the PCR product was run in 1.5% of
agarose gel. The remaining PCR products for selected samples were purified for sequencing using
the RapidTip pipette tips following the manufacturer’s protocol (Diffinity Genomics, West
Chester, Pennsylvania), quantified using Hoechst 33258, mixed with 5uM of either forward or
reverse primer, then submitted for capillary sequencing (Eurofins Genomics, Louisville, KY). AB1
files were viewed, aligned to the CPQ gene, and further analyzed using SeqManPro 17
(DNASTAR, Madison, WI).
Exonuclease Allelic Discrimination Assay (SNP genotyping)
TaqMan 5’-exonuclease assays were used for genotyping the birds based on specific SNPs
in the CPQ gene. Quantitative PCR (qPCR) was in a CFX96 real-time thermocycler (Bio-Rad
Laboratories, Inc., Hercules, California). The total volume for each reaction was 20 ul containing
the previously mentioned PCR reagents plus 0.25 uM of the two probes (Table 2.1). The PCR
cycling was 90 ℃ for 30 seconds, 10 cycles of 90℃ for 15 seconds, and a specific annealing
temperature as shown in Table 2.1 for 60 seconds, followed by 30 cycles of the same temperatures
and times including plate reads after each cycle. Each sample was run in triplicates, and the
amplification profile was examined to score the birds for specific genotypes. Selective qPCRs were
confirmed for genotype by capillary sequencing (see above).
Measuring the Expression of the CPQ gene
Tissue Collection and Preparation
At six weeks of age, seven males and five female birds with particular genotypes were
euthanized either by cervical dislocation or CO2 inhalation. The tissue samples (breast, heart, thigh,
spleen, liver, thymus, lung, and kidney) were collected immediately at necropsy. Samples were
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placed in RNA Later (Thermo Fisher Scientific, Waltham, MA) in 2 ml microfuge tubes. The ratio
of the RNA Later to tissue was at least 10:0.5 (v:v). The tube was mixed well, equilibrated at 4℃
overnight, and then stored at -20℃ until RNA extraction.
RNA Extraction, cDNA Synthesis, and Gene Expression Assay
Samples were homogenized using a Bullet Blender, as above. The homogenate was
extracted using the Trizol Reagent (Thermo Fisher Scientific, Waltham, MA) based on Trizol RNA
Isolation Protocol. The extracted RNA was assessed for purity (A 260/280) and quantity using
NanoVue spectrophotometry (GE Healthcare Biosciences, MA, USA). The minimum A 260/280
ratio was 1.6. RNA integrity was assessed by running 5 ul of the isolated RNA by electrophoresis
in 1.5% agarose gels in 0.5X TBE (50 mM Tris, 25 mM Borate, 1 mM Na2EDTA, pH 8.3).
Ethidium bromide (0.5ug/ml) was used for staining. The gels were scanned for fluorescence (ex
523 nm: em 600 nm) using a Typhon 9600 scanner (GE Health Care, Piscataway, NY). All the
RNA samples showed three strong bands of different sizes (5S, 18S, and 28 S rRNA). RNA
samples were tested for genomic DNA contamination using primers specific to genomic DNA to
confirm no amplification of a specific PCR product. Five micrograms of total RNA were used for
first-strand cDNA synthesis using SuperScript III Reverse Transcriptase (Thermo Scientific, USA)
based on the manufacturer’s instructions. Single-step RT-qPCR was in a CFX96 real-time
thermocycler (Bio-Rad Laboratories, Inc., Hercules, California) to measure CPQ gene expression
level. The total reaction volume was 20ul, and each reaction had the previous PCR reagents with
the target-specific primers (Table 2.1) plus 1x EvaGreen dye (Biotium Inc., Fremont, CA). Each
assay was in triplicates with negative (no DNA) control. The PCR protocol was the initial
denaturation at 90℃ for 30 seconds, 10 cycles of 90℃ for 15 seconds, 55℃ for 30 seconds, 72℃
for 60 seconds, followed by 35 cycles of the same temperature and time with each cycle followed
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by a plate read. To confirm the product specificity, a high-resolution melt (HRM) curve was
performed post PCR. TATA-box binding protein (TBP) gene was used as a reference to normalize
gene expression data (Radonić et al., 2004). Ct data were analyzed in Microsoft Excel to compute
ΔCt and ΔΔCt (Avg.).
Statistical Analysis
All statistical calculations were done in Excel. The student T-test was used to determine
whether there is a significant difference between different genders with different genotypes within
the same line. A significant difference was assumed with a p-value < 0.05.

RESULTS
In a previous study, CPQ gene expression was evaluated for an association between
different genotypes with gene expression levels (Dey et al., 2018). The gene expression assay was
performed on healthy six-week-old REL line birds with different genotypes (homozygous
reference, heterozygous, and homozygous non-reference for intron 6 SNPs). Expression focused
on the lung, heart, and liver, as these may be the organs most impacted by ascites. The expression
results revealed that homozygous birds homozygous for the non-reference SNPs showed the
highest gene expression in all three tissues (lung, heart, and liver) (Dey et al., 2018). Therefore,
we aimed to determine the potential effect of genotype on CPQ gene expression in additional
tissues. Eight tissues (breast, heart, thigh, spleen, liver, thymus, lung, and kidney) were chosen
based on the expression of CPQ in Homo sapiens (NCBI RNAseq summaries). The selected tissues
were collected from unchallenged, six-week-old REL line birds from both genders with specific
genotypes. The relative gene expression level was determined using RT-qPCR, using TBP as
reference (Table 2.2). We found that CPQ gene expression level was significantly increased in the
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liver of homozygous non-ref males (p-value = 0.0080). However, there are no significant
differences in the CPQ expression level in other tissues from homozygous non-ref males and all
tissues from homozygous non-ref females. We could not measure the gene expression for some
heterozygous male birds even though we designed multiple primers to amplify various exonic
regions of the gene including exons 5, 6, 7, and 8. High-Resolution Melt (HRM) analyses post
PCR implied no specific amplification in these particular samples (Figure 2.1). The PCR products
were evaluated by agarose electrophoresis to further confirm the lack of specific PCR products
(Figure 2.2).
Further analysis was performed on previous next-generation sequencing (NGS) data
obtained from REL line birds phenotyped for ascites in the hypobaric chamber. The NGS data was
for 8 libraries prepared from eight pools of REL line DNAs with each pool containing DNAs from
10 birds of each gender and ascites phenotype (resistant or susceptible) with two replicates (eight
pools representing 2 phenotypes x 2 genders x 2 replicates). The Illumina HiSeq 2500 was used to
sequence each pool and generate data with approximately 67Gb from each pool. Then, DNAStar
NGen was used to align the sequence reads to the Gallus_gallus-6 genome. The alignments were
quantified for SNPs and CNVs using ArrayStar. The NGS analyses included read depth for NGS
data from each pool. Our NGS results showed that there are significant differences in SNP
frequencies in the CPQ gene region. There was an obvious decline in the NGS read depth starting
from around 126,970k to 127,095k, suggesting a chromosomal deletion of approximately 125kbp.
Thus, some birds appear to carry a deletion of this region beginning in intron 4 (Figure 2.3) to
~40kbp downstream of exon8 (Figures 2.4). Further analyses were performed on resistant and
susceptible REL males and females to determine if this chromosomal deletion affected ascites
resistance and susceptibility. In Figure 2.5, the read depth for the phenotype pools is plotted with
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orange dots for resistant (R), and gray dots for susceptible (S). There are more reads in the deletion
region of resistant females than susceptible females, whereas susceptible males have more reads
in the region of the deletion than the resistant males, suggesting that the chromosomal deletion is
more frequent in resistant females and susceptible males. Therefore, this chromosomal deletion
may be associated with both resistance and susceptibility.
Two probes (exon 2 vs. exon 8) were designed for the exonuclease qPCR test to genotype
different target DNA samples for the deletion. The TaqMan assay was applied first to archived
DNA samples from the REL line phenotyped for ascites (resistant and susceptible) in the hypobaric
chamber and genotyped for CPQ-intron 6 SNPs as either homozygous ref [T/A], heterozygous
[Y/M], homozygous non-ref [C/C] (Dey et al., 2018). Exon 2 and exon 8 primers and probes (Table
2.1) were used as a way to screen the birds for deletion. We genotyped over 175 DNA samples
from REL line birds by visually inspecting the amplification profile and scored them for “without
the deletion” or “with the deletion”. Specifically, if the amplification profile shows two signals,
“HEX and FAM”, the sample lacks the deletion. While, if the amplification profile shows one
signal “FAM”, it means that the sample contains the deletion. Then, a statistical analysis was
performed to obtain p-values for the Chi-test of observed vs expected. Our results revealed that
there is a significant association (p-value = 0.048) between this chromosomal deletion and intron
6 heterozygous birds with the deletion. However, this association does not apply to the
homozygous ref birds with the deletion (p-value = 0.41) and the homozygous non-ref birds with
the deletion (p-value = 0.081) (Table 2.3). To clarify, the 125kbp chromosomal deletion might
increase the ascites resistance and susceptibility in heterozygous birds only, whereas neither
homozygous ref nor non-ref birds are affected by the deletion.
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An additional 27 DNA samples were genotyped for the deletion. These were REL line male
birds for which we had produced RNAseq data for the right heart ventricle. The samples were from
healthy birds raised at low altitudes and birds with and without ascites raised at simulated high
altitudes in the hypobaric chamber (Licknack, unpublished). The main goal of the RNAseq
experiment was to quantify the transcriptomic alterations in the right ventricle upon hypobaric
challenge and then with the development of ascites. The birds were phenotyped for ascites
resistance (No Ascites “NA”) and susceptibility (Ascites “A”) and genotyped for the specific CPQ
SNPs in intron 6 and exon8 (Table 2.4). For the intron 6 CPQ SNPs, 37% of the homozygous nonref birds (C/C) were resistant, 30% of the homozygous non-ref were susceptible, and 15% of the
homozygous ref (T/A) were resistant, and 4% of the homozygous ref were susceptible. The
heterozygous birds (Y/M) showed an equal percentage of resistant and susceptible (~7.4%). For
the exon 8 CPQ SNP, 30% of the homozygous non-ref birds (C/C) were resistant, 30% of the
homozygous non-ref were susceptible, and 15% of the homozygous ref (G/G) were resistant, and
7.4% of the homozygous ref were susceptible. Almost 15% of the heterozygous birds (C/G) were
resistant, while only 4% were susceptible. For the chromosomal deletion analysis, we ran all the
27 DNA samples by qPCR with different primers flanking the deletion (CNVFxR, CNVF1xR1,
CNVF1xR2; Table 2.1). The PCR product was sent for sequencing for further confirmation and to
specifically map the recombination breakpoint. The results suggested that 100% of the birds with
genotypes for intron 6 and 8 of CC-S or YM-S contained chromosomal deletion. Meanwhile, 50%
of the birds with the YM-C genotype contained the deletion. The most plausible explanation for
such findings is that the birds must be either triploid or higher for this region for birds to be
heterozygous for SNPs in intron 6 and 8 but yet contain a deletion spanning both intron 6 and exon
8. To clarify, the CC-S birds are heterozygous for exon 8, and yet there is at least one copy that is
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deleted. Moreover, the YM-C birds are heterozygous for intron 6 and contain a copy that is deleted
(Table 2.4).
Sanger sequence analysis of PCR products from birds carrying the deletion localized the
recombination site to a 3-base region (Figure 2.7). To illustrate, both left and right boundaries are
connected at the recombination point TCC. Within the approximately 125 kbp deletion, there are
44 long interspersed nuclear elements (LINEs) (Figure 2.6), The SeqManUltra alignment was used
to align the two LINEs that appear to have recombined as the left and right boundaries. The left
and right deletion LINEs were downloaded from the UCSC genome browser and aligned with
sequences from three deletion PCR products (Figure 2.7). Our SeqManUltra analysis proved that
two LINEs connect the left to the right flank at the recombination point TCC. These two LINEs
belong to the CR1 family (Figure 2.6). These data indicated that the REL line birds have a large
heterozygous deletion (~125kbp), including exons 5-8 of the CPQ gene.

DISCUSSION
The Carboxypeptidase Q (CPQ) gene or human plasma glutamate carboxypeptidase
(PGCP) gene, which encodes a metallopeptidase, is a member of the peptidase M28 family. The
molecular weight of its functional protein is 56-kDa and plays a significant role in the cleavage of
hydrophobic amino acids in the circulating dipeptides (Gingras et al., 1999). The CPQ has been
found to facilitate the hydrolysis of thyroglobulin (Tg) precursor into thyroxine (Ahmetov et al.,
2016). In humans, this gene showed an association with blood pressure, hypertension,
electrocardiography, and heart rate. Its functional protein is conserved in all vertebrates. The CPQ
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protein in chickens shows an identity of 70% to other vertebrates such as rats, mice, monkeys, and
humans (Dey et al., 2018).
In a previous study, the genotyping data of different broiler lines revealed that homozygous
non-ref birds (for both intron 6 SNPs and exon 8 SNP) are more resistant to ascites. This
relationship is more pronounced in males rather than females. The heterozygous genotype does
not show a high ascites resistance, suggesting that the non-ref allele is recessive. The exon 8 SNP
changes the encoded proteins with lysine at 444 residue substituted by asparagine (K444N). This
substitution occurs in the exposed region of the enzyme, not in the catalytic site. Thus, K444N
would impact protein-protein interactions and possibly affect the activity of CPQ on circulating
dipeptide hormones responsible for the homeostasis of blood pressure. Previous gene expression
data showed that homozygous non-ref birds had a higher gene expression in three major tissues
(heart, lung, liver) compared to the homozygous ref. This indicates that the non-ref SNPs in the 3'
region of the CPQ gene may influence regulatory DNA sequences which then alter gene
expression. However, in our study, the gene expression results disagree that heart and lung do not
show a high expression level of CPQ mRNA in homozygous non-ref in both genders. In addition,
other tissues including, the breast, thigh, spleen, thymus, and kidney, show normal gene
expression. We only observed a significant gene expression in the liver of homozygous non-ref
males relative to homozygous ref males (Table 2.2). This suggested that the CPQ gene is regulated
in a gender-specific manner where it is highly expressed in the major ascitic organ, and the mature
protein or its mRNA level increases the ascites resistance.
Analysis of previous NGS data demonstrates a chromosomal deletion of 125kbp in the
CPQ gene region to 40kbp downstream of exon 8. The role of this chromosomal deletion on ascites
is still under investigation since both genders from the same line showed different associations.
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Ascites or pulmonary hypotension is a metabolic disease in broilers with higher body weight.
Generally, male broilers have a higher body weight than females, so they are more likely to develop
ascites due to their high oxygen demand (Closter et al., 2012). The manifestation and effect of
ascites are more prominent in males. Therefore, this chromosomal deletion could be associated
with ascites susceptibility.
Our sequence analyses revealed that 100% of the birds with intron 6+exon 8 SNP
genotypes of CC-S or YM-S showed chromosomal deletion. The genotype CC-S consists of
homozygous non-ref for intron 6 SNPs and heterozygous for missense exon 8 SNP. Dey et al.
(2018) demonstrated that this genotype shows a strong association with ascites resistance and high
CPQ gene expression. Nevertheless, our gene expression data argue that this genotype showed no
expression in eight tissues This might occur due to the chromosomal deletion starting from intron
4 to 40kbp downstream of exon 8, suggesting that this deletion could increase the ascites
susceptibility.
Even though the CPQ gene shows a strong relationship with high blood pressure and
hypertension in humans, the main role of its mature protein is unknown. Dey et al. (2018) showed
a positive correlation between the CPQ gene and avian pulmonary hypertension. Another study
showed that broilers with pulmonary hypertension developed plexiform lesions similar to those in
humans (Wideman et al., 2013). These new data agree with Dey et al. (2018) that the CPQ gene
is highly expressed in the liver for some alleles. This may contribute to having a better
understanding of the role of this gene in human hypertension as well as developing new treatments
for some forms of human hypertension. Moreover, the thyroxin hormone is released through the
hydrolysis of thyroglobulin by CPQ protein (Luger et al., 2001). This hormone is tri-iodinated in
the kidney and liver, and it is secreted in broilers under normal environmental and physiological
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conditions such as low temperature, a higher metabolic rate, and increased oxygen demand. The
thyroxin hormone is significantly upregulated in the plasma of unaffected birds, while the affected
birds are not able to generate a sufficient amount of this hormone. Thus, a higher expression level
of the CPQ gene in homozygous non-ref males would provide the birds with ascites resistance
because they could increase the production of thyroxin during a high metabolic rate and increase
oxygen demand (Luger et al., 2001). However, the lack of gene expression in heterozygous
recombinant (CC-S) birds with the deletion are prone to ascites development. Therefore, the
plasma thyroxin level is not sufficient, which inhibits the birds from adapting to hypoxia.
In summary, our gene expression results showed that the CPQ gene is normally expressed
in all tissues except the major ascitic organ (liver). The overexpression in the liver is considered
gender-specific since it has been observed in broiler males but not in females. Further NGS
analysis proved that some heterozygous birds showed a deletion affecting the 3’ end of the CPQ
gene. However, our results did not strongly support the association between the 125K
chromosomal deletion and ascites phenotypes. Therefore, this chromosomal deletion is still a
candidate region for future study of relevance to ascites or pulmonary hypertension in broilers.
Our new findings give significant hints to recognizing the mechanisms that underlie this deletion
and affect the ascites phenotypes.
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TABLES AND FIGURES
Table 2. 1.primers, probes, and conditions for qPCR, PCR, and RT-qPCR. For each CPQ SNP locus: position is the base pair
position on chromosome 2 according to the 2015 genome assembly; Primers are 5’-3’ for forward (F-) and Reverse (R-); Probes are 5’3’ associated with SNP127.70, and the first allele (P1TA/CC) is labeled with FAM while the second allele (P2TA/CC) is labeled with
HEX. The melting temperature (˚C) is the temperature used for both qPCR and RT-qPCR. The highlighted red SNPs are the SNPs being
used for genotyping.
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Assay

Locus

Position (bp)

Primers/Probes (5’>3’)

˚C

CPQ intron 6
SNPs

CPQ 127.705F

Chr2:127670338

Cctaattgcactgcctttgc

60

CPQ 127.705R

Chr2: 127670568

Actgattctgtggccttcct

CPQp1TA/CC

Chr2: 127670526

HEX-ctacaataaaaagaagagttgattc

CPQp2TA/CC

Chr2: 127670526

FAM-ccacaatacaaagaagagttga

CPQex8F

Chr2:127708143

CGTGATGACCTCAGTAAATACTTCTGG

CPQex8R

Chr2:127708591

CCTGCTGCAAAGGATAAGTTTGCATAC

CPQex8P1

Chr2:127708196

HEX-TGCTTTGGATCCTGAACTGTC

CPQ exon 8
SNPs

CPQex8P2
CPQ RT-qPCR

56

FAM-TGGTTTGGATCCTGAACTGTC

CPQ_cDNAex7F

Chr2:127677758

CAATTTCTGGATGAGGGACGGAG

CPQ_cDNAex8R

Chr2:127708283

CAGCATCTCCTCCATGTCAGC

CPQex5F

Chr2:127649442

CGGAGGAGCATTTATATCATGGG

CPQex6R

Chr2:127664424

TGTTCTTCTCCTGTCCATAGCA

CPQex6F

Chr2: 127664446

AGGAGGAATAGGTGCTGAGC

CPQex7R

Chr2:127677761

CTCCGTCCCTCATCCAGAAA

55

Table 2.1. (continue).
Assay
Locus
TBP RT-qPCR

CPQ deletion
SNPs
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CPQ left and
right boundaries
SNPs (CNV)

Position (bp)

Primers/Probes (5’>3’)

˚C

TBPF

Chr3:40848487

GAACCACGTACTACTGCGCT

55

TBPR

Chr3:40846952

CTGCTGAACTGCTGGTGTGT

CPQx2F

Chr2:127564601

Gccacgatatgctggcaggt

CPQx2R

Chr2:127564355

Gcacattctccagcccgtct

CPQx2P

Chr2:127564398

HEX-ccaaaagcatttgaaggcatcag

CPQx8F

Chr2:127708135

Ccagcttgcgtgatgacctc

CPQx8R

Chr2: 127708376

Cgtgcaaaatcagggtgaaaaaagg

CPQx8P

Chr2:127708226

FAM-ctgtgctgctgtttggactg

CPQCNVF

Chr2:127627767

ACCGCACATCTTGGCATCAT

CPQCNVR

Chr2: 127756139

GTGGCAGGGGAACTAAGGTT

CPQCNVF1

Chr2:127627825

AGTGCAGGTCCAGAGATTCCA

CPQCNVR1

Chr2:127756140

TTGTGGCAGGGGAACTAAGGT

CPQCNVR2

Chr2:127756161

Gcaacgaggagcctacatcat

61

69

Table 2. 2.The CPQ mRNA expression values for homozygous non ref REL line compared to the homozygous ref using TBP as
a reference. Higher expression of the gene is considered at P<0.05.
Tissue Type

Male

p-value

Female

FC

p-value

FC

0.322

0.096

0.39

0.42

Heart

0.44

0.002

0.34

0.46

Thigh

0.069

0.079

0.27

0.007

Spleen

0.15

0.039

0.48

0.011

Liver

0.008

0.0022

0.40

0.22

Thymus

0.136

0.017

0.20

0.015

Lung

0.36

0.060

0.26

0.27

Kidney

0.23

0.016

0.41

0.51

89

Breast

Table 2. 3.Genotype data for CPQ-intron 6, exon2, and exon 2 and 8 for REL line. The genotype frequencies were determined
for the ascites susceptible (S) and resistant (R). The REL line samples were genotyped for intron 6 and the deletion based on
their gender. The p-values for a simple Bonferroni (Adj Pval) of chi square test of observed vs. expected are present.
With the deletion
Line

REL

Genotype

All
Count

TA

Male
S
Freq
0

Adj
Pval
1.005

Count

2

R
Freq
0.071

1

Female
R
S
Freq
Freq
0.055
0

0.048

18

0.32

0.69

0.28

12

0.22

0.66

0.178

0.081

21

0.60

0.30

0.63

17

0.72

0.33

0.49

Adj
Pval
1.47

R
Freq
0.065

S
Freq
0

Adj
Pval
0.41

Count

3

All
Freq
0.036

YM

35

0.42

0.28

0.64

CC

45

0.65

0.35

0.54

Adj
Pval
1.24

Without the deletion
Line

Genotype

All
Count

TA

S
Freq
0.315

Adj
Pval
1.900

Count

12

R
Freq
0.24

7

Female
R
S
Freq
Freq
0.15
0.25

0.66

2

0

0.10

0.31

4

0.1

0.125

2.44

1.004

30

0.76

0.57

1.41

26

0.75

0.625

1.96

R
Freq
0.19

S
Freq
0.30

Adj
Pval
0.96

Count

23

All
Freq
0.25

YM

6

0.065

0.043

0.11

CC

63

0.68

0.76

0.58

90
REL

Male

Table 2. 4.Genotype data for CPQ-intron 6, CPQ-exon 8, and chromosomal deletion for 27 REL line samples. This table
includes all the significant information for those samples involving the samples number, the wing band number, and the
genotyping based on PCRseq. Only six birds showed a heterozygous deletion.
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Sample
#

Wing
band
#

Genotyping
of intron 6
based on
PCRseq

Genotyping
of X8 based
on PCRseq

1
2
3
4
5
6
7
8
9
10
11
12
13
14

12014
11818
11954
11906
11979
12011
12198
11926
12190
12022
11973
11901
12185
12086

TA
CC
TA
CC
CC
TA
YM
TA
CC
TA
CC
CC
CC
CC

C
G
C
C
G
C
C
C
G
C
G
G
C
S (C/G)

Phenotype
(NoAscites
“NA” or
Ascites
“A”)
NA
NA
NA
A
NA
NA
A
A
A
NA
NA
NA
NA
NA

Sample#

Wing
band
#

Genotyping
of intron 6
based on
PCRseq

Genotyping
of X8 based
on PCRseq

15
16
17
18
19
20
21
22
23
24
25
26
27

12056
11890
12043
12105
12168
12044
12164
12017
12167
12009
12117
12050
12159

YM
YM
CC
CC
CC
YM
CC
CC
CC
CC
CC
CC
CC

G
C
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Figure 2. SEQ Figure_2. \* ARABIC 1.CPQ mRNA expression levels assayed by RT-qPCR for CPQ gene in eight tissues
breast, heart, thigh, spleen, liver, thymus, lung, and kidney) in heterozygous using PCR primers flanking exon 7 and 8. The
amplification profile shows that heterozygous samples amplify with both TBP and CPQ primers. However, the High-Resolution
Melt (HRM) analyses post PCR implied no specific amplification in these particular samples.

Kidney

Lung

Thymus

Liver

Spleen

Thigh

Heart

Heterozygous

Breast

100bp Ladder

Kidney

Lung

Thymus

Liver

Spleen

Thigh

Heart

Breast

Homozygous

Figure 2. 2.Agarose gel (1.5%) of CPQ mRNA expression levels assayed by RT-qPCR for
CPQ gene in eight tissues (breast, heart, thigh, spleen, liver, thymus, lung, and kidney) in
homozygous and heterozygous using PCR primers flanking exon 7 and 8.
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125 Kilobase deletion

Figure 2. 3.NGS: A 125-kb deletion is seen by a significant decline in NGS read depth.
Deletions from 126,970k to 127,095k = 125kbp.
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Figure 2. 4.NGS: A 125-kb deletion is evidenced by a significant decline in NGS read coverage. The deletion appears to span
from 126,970k to 127,095k = 125kbp.
95

A.
A.

B.
96

B.

Figure 2. 5.Depiction of significant chromosomal deletion in both R=resistant and S=susceptible for M=males and F=females.
A is the read depth in females while B is for males.
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Figure 2. 6.A general picture of the long interspersed nuclear elements (LINEs) identified in
the CPQ gene and CPQ gene deletion region using the UCSC genome browser. Panel A shows
the number of LINEs in the CPQ gene region (red bracket delimits the deletion). Panel B is the
LINEs present at the left boundary. Panel C is the LINE present at the right boundary.
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Figure 2. 7.Identification and analysis of 125kbp in CPQ gene. A different set of primers for CNVs (CNVFR, CNVF1R1, CNVF1R2)
were used to amplify the recombination junction (red box), and the sequencing results were comparted with the available chicken
genome sequence (Galgal6). The left and right LINEs sequences were downloaded from the UCSC genome browser and aligned with
the three PCR products using the SeqManUltra to recognize the recombinant point.
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ABSTRACT
Pulmonary hypertension syndrome (PHS) is a multifunctional metabolic disease, affecting
broiler chickens. These broilers show a distended belly formed from the accumulation of the fluid
in the abdominal cavity. This disease is a major issue in the poultry industry due to considerable
economic losses annually. We analyzed three different phenotypic groups in this study: nonchallenge with no ascites “NC-NA”, challenge with no ascites “C-NA”, and challenge with ascites
“CA”. The challenge was exposure to hypoxic conditions in a hypobaric chamber. Proteomic and
metabolomic changes in the plasma of the healthy birds (NC-NA, C-NA) and affected birds (CA)
were explored using tandem mass spectrometry (LC-MS)/MS), gas chromatography-mass
spectrometry (GC-MS), and liquid chromatography-tandem mass spectrometry (LC-MS) to
identify molecular biomarkers in proteins, total fatty acids, lipids, and small molecules. The LCMS)/MS spectra analysis illustrated elevated levels of apolipoprotein A-I (APOA1), ovotransferrin
(TF), hemoglobin subunit beta (HBBA), beta-2-glycoprotein 1 precursor (a protein induced by
APOH gene), angiotensinogen (AGT), peroxiredoxin-1 (PRDX1), calcium-binding protein (P22),
prothrombin (F2), and coagulation factor IX (F9) and reduced level of fibrinogen alpha chain
(FGA), fibrinogen gamma chain precursor (FGG), fibrinogen beta chain (FGB), fibronectin (FN1),
IgG Fc-binding protein (FcγBP), complement factor H isoform X1 (produced by CFH gene),
glutathione peroxidase (GPX3) and von Willebrand factor precursor (VWF) with the onset of
ascites. The GC-MS spectra analysis showed a reduced level of stearic acid (C18:0), oleic acid
(C18:1), and linoleic acid (C18:2) concerning ascites. The LC-MS spectra analysis illustrated a
high level of phosphatidylcholine (PC) (34:2), PC (38:3), PC (38:1), PC (36:5), PC (36:3), PC
(36:2), PC (40:1), PC (36:1), PC (40:0), and cholesterol ester (CE) 16:1 and a low level of PC
(36:4; O) in the plasma for the affected broilers. Further small molecule analysis showed a higher
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abundance of PC (18:2(9Z,12Z) \/0:0), PC (0:0/18:1(6Z), LysoPI (20:4(5Z,8Z,11Z,14Z)/0:0), PC
(0:0/16:0), phosphatidylethanolamine (PE) (18:2(9Z,12Z)/0:0), and PC (14:0/O-1:0) and a lower
abundance of ubiquitin, L-aspartyl-L-glutamate and dehydroepiandrosterone sulfate in response
to ascites. These results suggest that these proteins, fatty acids, lipids, and small molecules might
be beneficial as noninvasive biomarkers for pulmonary hypertension or ascites in broilers.

KEYWORDS: ascites, proteomics, metabolomics, upregulated, downregulated, proteins, fatty
acids, lipids, small molecules, LC-MS/MS, GC-MS, LC-MS.
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INTRODUCTION
Pulmonary hypertension syndrome (PHS) or ascites syndrome (AS) is a multifactorial
metabolic disease influenced by physiological, environmental, genetic, and nutritional factors
(Decuypere et al., 2000; Baghbanzadeh, & Decuypere, 2008). PHS is characterized by several
structural alterations involving thrombosis, vasoconstriction, and adverse pulmonary vascular
remodeling, resulting in elevated arterial pressure, right ventricular hypertrophy (RVH), and ends
up with heart failure (Peacock, 1990; Cottrill & Chan, 2013; Lannan et al., 2014). PHS is caused
by elevated blood flow or pulmonary vascular resistance (Julian, 1986). Prolonged PHS, which is
driven by increasing demand for oxygen, leads to liver damage and fluid accumulation in the
abdominal cavity (Buys, 1999; Luger et al., 2003; Singh et al., 2011). PHS is a worldwide issue
and seems to be a common disease in poultry because modern boilers are more susceptible to it
(Olkowski, 2007; Wideman et al., 2013; Khajali & Wideman, 2016; Biswas, 2019). This is
problematic for the poultry industry since %5 of broilers dies after ascites development (Wang et
al., 2012). There was an estimation of economic loss of $ 1 billion/per year due to PHS (Maxwell,
1997; Jacobson & Brownell, 2000; Wideman et al., 2001). Identification of biomarkers for the
early stages of PHS would be valuable in monitoring the disease (Rafikova et al., 2016). Idiopathic
pulmonary hypertension (IPAH), in humans, remains a serious and progressive disease with an
unknown cause that often leads to a failure in the right ventricle (RV), considerable morbidity, and
early mortality (Firth et al., 2010; Mathai & Hassoun, 2012). There is no specific remedy for IPAH
even though significant advancements have been recently achieved in its pathology (Barst, 1999;
Humbert et al., 2014). Animal models have been used in IPAH studies to simulate the clinical
pathophysiology of this disease (Zaiman et al., 2005; Firth et al., 2010).
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At the University of Arkansas, fast-growing broilers have been used as models for PHS
studies due to their breeding feasibility and short generation interval. Relax unselected (REL) line,
susceptible (SUS) line, and resistant (RES) line are three research lines developed through
divergent selection by Dr. Anthony and his associates. PHS was induced by raising the broilers in
a hypobaric chamber to mimic the high altitude (9000ft above sea level) (Pavlidis et al., 2007). At
the end of the experiment, three groups were developed: non-challenge with no ascites (NC-NA),
challenge with no ascites (C-NA) and challenge with ascites (CA).
Proteomic and metabolomic studies help researchers in exploring specific proteomes and
metabolomes directly involved in a targeted disease state (Hu et al., 2020). Previous studies have
used proteomic and metabolomic profiles of PHS to detect associated molecular biomarkers in
broilers (Wang et al., 2012; Shen et al., 2014; Shi et al., 2017; Ge et al., 2020). In the current
study, we have conducted proteomic and metabolomic studies on male broilers from three different
groups (NC-NA, C-NA, CA) to identify proteins, total fatty acids, lipids, and small molecules that
contribute to the disease. The major aim of this study is to find molecular biomarkers prior and
post PHS development. Then, we linked the identified molecular biomarkers to several biological
processes and pathways to know which pathways/processes responded to the challenge and
disease.
In this study, all the experiments were performed on plasma samples with six replicates for
each group (NC-NA, C-NA, CA) obtained from REL line male birds at 2 weeks of age. Proteins
and metabolites (fatty acids, lipids, and small molecules) were extracted and submitted for mass
spectrometry analysis. The generated data were further analyzed using various bioinformatics
programs to compare significantly proteomic and metabolomic changes (p-value <0.05) in NCNA relative to C-NA and C-NA relative to CA (Figure 3.1).
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MATERIALS AND METHODS
Birds Stock and Sample Collection
All animal procedures took place at the University of Arkansas Poultry Research farm.
This work followed procedures approved by the University of Arkansas Institutional Care and Use
Committee; protocol number (Approval Numbers 15039, 15040, 21087, 21088). Three groups
were taken from an unselected relaxed (REL) line at the 18th generation, which was randomly
mated. Then, the chicks were moved to cages in a hypobaric chamber for six weeks to produce the
Challenged group, or to identical cages at ambient pressure (2700ft) to produce the Unchallenged
group. Both chambers and cages were provided with a mesh floor, trough feeders, and nipple
water. The hypobaric chamber’s simulated altitude was set to 9500ft, and the airflow was adjusted
to 17 m3/min. The initial temperature in the hypobaric chamber was 90 oF and was gradually
dropped to 80 oF over time until the sampling date (Balog and Anthony, 2000; Tellez et al., 2005;
Pavlidis et al., 2007). A daily mortality rate was recorded, and necropsy was done on the dead
birds to identify the major cause of the death and determine the bird's gender. Birds with ascites
were identified based on the presence of ascitic fluid in the abdominal cavity (Druyan et al., 2007;
Tarrant et al., 2017). In addition, there are other symptoms associated with ascites including right
ventricle to total ventricle ratio, a flaccid heart, and liver lesion (Dey et al., 2018). Blood samples
were collected from 2 weeks old male broilers for plasma extraction as described previously
(Chamorro et al., 2013) for further proteomic and metabolomic studies. At six weeks of age,
surviving birds were terminated by cervical dislocation and assessed for ascites phenotype
(Pavlidis et al., 2007; Tarrant et al., 2017). Three groups were identified at the end of the
experiment: non-challenge with no ascites (NC-NA), challenges with ascites (CA), and challenges
with no ascites (C-NA).
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Plasma Sample Preparation for Proteomic, Lipidomic, Metabolomic, and Total Fatty Acids
Analysis
A total volume of 80ul of plasma sample was mixed with 1.5ml of the extraction solvent
Chloroform/Methanol/Water in a1:3:1 ratio in 2ml Eppendorf tube. The mix was vortexed for 20
seconds, stored at 4oC for 5 minutes, and then centrifuged at 13000g for 3 minutes at 4oC. The
supernatant from each tube was transferred to a 2ml glass screw-top vial. Both the supernatant and
pellet were stored at -80oC. The supernatant was submitted for total fatty acids, intact lipids, and
small molecules analyses using Gas Chromatography-mass spectrometry (GC-MS), Liquid
Chromatography-Mass Spectrometry (LC-MS), and Liquid Chromatography-Tandem Mass
Spectrometry (LC-MS/MS), respectively (Fang et al., 2015; Warren, 2018; Serafim et al., 2019).
Pellets were used for protein analysis as described below. To prepare a quality control (QC)
sample, an equal volume from each sample (both cases “C-NA and CA” and the controls “NCNA” and C-NA) was mixed.
Proteomic Analyses
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The plasma extract pellet was resuspended in a 2x Tris-glycine SDS loading buffer
(100mM Tris HCL: 4% SDS: 0.2% bromophenol blue:200mM dithiothreitol: 20% glycerol) at PH
6.8. A reducing agent (10x of 2-mercaptoethanol) was added to the samples, which were then
incubated for 2 minutes at 85oC. The protein samples, three biological replicates from each
condition (described), and a total of ten samples including the QC control, were loaded in a 4-20%
gradient tris-glycine gel (Navex Wedge Well, Invitrogen, Thermo Fisher Scientific). The gel was
run in 1x Sodium Dodecyl Sulfate (SDS) running buffer in 200V, 100mA, and stained with
Coomassie Brilliant Blue dye.
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Trypsin Digestion for Protein Identification
Each gel lane corresponding to biological samples was divided into five sections (Figure
3.2). Each subsection of the gel was cut into small pieces and washed with 1ml of 25mM
ammonium bicarbonate for 30 minutes. Then, the gel segments were destained with 50:50 H2O:
acetonitrile (ACN, Bio-Rad Laboratories, Hercules, CA, USA) in 25mM ammonium bicarbonate
for 60 minutes, followed by gel dehydration with 100% acetonitrile for 15 minutes. A protein
disulfide bond reduction was achieved by incubating the dried gel fragments for 60 minutes at
55oC in 10mM dithiothreitol (DTT, Bio-Rad) in 25mM ammonium bicarbonate. The excess DTT
was completely removed, then 55mM of iodoacetamide (IAA, Bio-Rad) in 25mM ammonium
bicarbonate was added and incubated for 60 minutes in the dark at room temperature to
carbamidomethylate the cysteines after the reduction. The excess IAA was discarded, and the gel
segments were further washed with 25mM ammonium bicarbonate before being dehydrated with
ACN for 15 minutes. After that, the dehydrated gel pieces were dried by a vacuum and treated
with 10 ng/ul of MS Grade Trypsin in 25mM ammonium bicarbonate enough to cover the dried
gel pieces and stored at 4o C for 30 minutes to increase the penetration of trypsin into the dried
gel. This was followed by an extra 200ul of 25mM ammonium bicarbonate and incubation
overnight at 37oC. Gel supernatant, which contains all the tryptic peptides on the gel, was
transferred into a new Eppendorf tube. To extract the remaining tryptic peptides stuck in the gel,
the gel pieces were resuspended in 5% of formic acid with 60% of ACN. The gel segments were
briefly vortexed and then transferred and combine with the same Eppendorf tube. This solution,
which had all the tryptic peptides, was fully evaporated, and reconstituted in 50ul of 0.1% formic
acid before being used for proteomic analysis using Liquid Chromatography-Tandem Mass
Spectrometry (LC-MS)/MS).
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Mass Spectrometry Analysis for Proteomics
LC-MS/MS was performed using an Agilent 1200 series micro-flow high-performance
liquid chromatography (HPLC) coupled to a Bruker Amazon SL quadrupole ion trap mass
spectrometer (Bruker Daltoniks Inc., Billerica, MA, United States) with a captive spray ionization
source as described earlier. Tryptic peptides were separated by using a C18 capillary column (150
mm × 0.1 mm, 3.5 μm particle size, 300 Å pore size; ZORBAX SB) with 5–40% gradients of 0.1%
formic acid (solvent A) and ACN in 0.1% formic acid (solvent B). Solvent flowed at a rate of 4
μL/min over 300 min each.
Bruker Data Analysis 4.0 software was used to generate peak lists from LC-MS/MS
chromatogram for Mascot database search using MASCOT v 2.2 search engine (Matrix Science).
In the Mascot search, parent ion and fragment ion mass tolerances were set at 0.6 Da with cysteine
carbamidomethyl fixed modification and methionine oxidation as variable modifications. For the
identification of proteins, a Mascot search was performed against the Gallus UniProt database.
Proteins identified with a 95% confidence limit were further filtered by considering the false
discovery rate (FDR). Only the proteins that fall into less than 5% FDR were used. FDR was
calculated in during the Mascot search by simultaneously searching the reverse sequence database.
Uncharacterized Gallus proteins were identified based on gene sequence similarities tentatively.
For evaluation of differentially expressed proteins, Mascot.dat files were exported to Scaffold
Proteome Software version 5.0.1 (http://www.proteomesoftware.com), and quantitative
differences were determined based on a 95% confidence limit.
The protein functional annotation was determined using David Functional Annotation
Bioinformatics Microarray Analysis (DAVID Functional Annotation Bioinformatics Microarray
Analysis (ncifcrf.gov) and PANTHERdb ( www.pantherdb.org). To obtain associated KEGG and
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Reactome pathways and protein-protein interactions, the differential expressed proteins were
submitted to STRING (STRING: functional protein association networks (string-db.org).
Fatty Acids Methyl Ester Preparation for Total Fatty Acids Analysis
Nitrogen gas was used to dry 100ul of plasma extract supernatant, and 1ml of 2% of
sodium methoxide (Sigma Aldrich, St.Louis, MO, USA) was directly added to the dried samples.
The samples were incubated for one hour at room temperature. The solution was transferred into
a 5ml glass vial. The fatty acid methyl esters (FAMEs) were extracted by addition of 1ml of water
plus 500ul of hexane, the solution was vortexed, then the top hexane layer was transferred to HPLC
vials. The FAMEs were resolved by Gas Chromatography-Mass Spectrometry (GC-MS) analysis.
Gas Chromatography/Mass Spectrometry
Samples were analyzed using Agilent 6890N gas chromatograph with 5973 single
quadrupole mass selective detector (GC/MS) equipped with Agilent 7683B autosampler. Agilent
30m G3903-63011 DB-FastFAME column with an internal diameter of 0.25 mm and 0.25 µm film
liquid layer was used for the analysis. One microliter of the sample was injected in spitless mode
into the injector port where the temperature was maintained at 280o C. Temperature of the oven
was changed linearly from 40o C to 220o C at the rate of 12o C/min followed by five minutes hold
at 220o C. The carrier gas was helium, and the flow rate is variable throughout the run as the
method used constant pressure. Electron impact ionization filament was turned on after 3.0 minutes
delay time to avoid the solvent front. The mass spectrometer was fully optimized using the
software so that all the lenses involved in ion extraction and the detector voltage were set to the
optimum values before running the assay. Quadrupole was also tuned and calibrated the same way
before the assay. The mass spectrometer was scanned in the m/z range of 30 - 500 in fast scanning
mode.
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Identification and Quantification of GC-MS data for FAMEs
Each of the fatty acid methyl esters were identified using their individual standard retention
times for the same GC-MS method used to analyze all the biological samples and using their NIST
(National Institute of Standards and Technology) 70 eV electron impact ionization fragment ion
spectra for the pure compound. FAMEs are quantified using total intensity normalization and these
normalized intensities were used for statistical analysis.
Lipid Analysis and Metabolomic Analysis (details)
Lipids and metabolites were analyzed using Shimadzu-IT-TOF high-resolution mass
spectrometer coupled to Shimadzu LC-20AD. Lipids were separated using two SunFire™ C18
columns (4.6 x 250 mm;5 µm) connected in series.

An isocratic gradient consisting of

isopropanol/methanol/chloroform (4:2:1, v/v/v) with 35 mM ammonium acetate was used as the
mobile phase, with a flow rate of 0.4 mL/min. Small molecule metabolites were separated using
a Bio-wide Pore C8 reverse phase column (4.6 mm × 15 cm, 5 μm) (Supelco, St. Louis, MO) was
used with a solvent flow rate of 0.7 mL/min using a 0.1% formic acid/acetonitrile gradient of 0–
100% over 70 min. Mass spectrometry analysis was conducted in positive ion mode.
Lipids and Metabolomics Data Analysis
Compounds lists containing mono isotopic m/z values and their corresponding intensities
for both lipids and metabolites were created using Shimadzu LabSolutions software. Lipids were
identified using exact mass and the fatty acid composition from FAMES studies. Metabolite
compounds were identified using exact mass as well as their fragmentation pattern. The mc ID
(http://www.mycompoundid.org/mycompoundid_beta2/doc/contact.jsp)

and

(https://msbi.ipb-halle.de/MetFrag/) were used to identify small molecule metabolites.

metFrag
Each

compound expression differences between different groups were calculated using the ratio (fold
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change) of the normalized intensities of the compounds in each condition. Volcano plots, log10(pvalue) as a function of log2(fold change) were created to visually recognize the differences between
groups for total fatty acids, intact lipids, and small molecules using the excel program. The pvalues less than 0.05 from the student T-test were used to determine the significantly changed
compounds/metabolites. MetaboAnalyst 5.0 (MetaboAnalyst) was used to identify the biological
pathways affected by PHS or AS. LIPIDS MAP (LIPID MAPS), Human Metabolome Database
(HMD)

(Human

Metabolome

Database

(hmdb.ca)),

(https://metlin.scripps.edu/landing_page.php?pgcontent=mainPage)

were

and
used

METLIN
to

identify

significantly changed metabolites.

RESULTS
Proteomics Identification and Quantification
In this study, the unselected REL line was raised at ambient pressure (2700t) to produce
non-challenge with no ascites (NC-NA) and in a hypobaric chamber (9500ft) to generate challenge
with no ascites (C-NA) and challenge with ascites (CA). Plasma samples were collected from three
different groups (NC-NA, C-NA, CA) for proteomic study. The proteomic data were undergone
two different comparisons using two different controls and two cases. The purpose of using two
controls and two cases in the current study is to look at the proteomic changes before and after
ascites development since both C-NA and CA were raised at high altitudes. In the first comparison,
NC-NA was the control, while the C-NA was the case. A comparison between NC-NA vs. C-NA
was applied to determine the differentially expressed proteins with respect to a hypobaric
challenge. In the second comparison, C-NA was the control, whereas CA was the case. C-NA was
compared to CA to identify the differentially expressed proteins with respect to ascites.
112

Based on the Scaffold Q+S viewer (version:5.0.1), a total of 148 individual proteins were
identified in broiler plasma. In terms of presence/absence (Figure 3.3A), 141 proteins were present
in all three treatments (NC-NA, C-NA, CA). There were 4 proteins (ovotransferrin “TF”, tubulin
alpha chain “TUBA1A1”, glutathione “GSTA4L”, coagulation factor IX “F9”) only identified in
the two challenged groups C-NA and CA, not in NC-NA. There were 2 proteins (histone H4 “H4I”, histone H2B “HIST1H2B5L”) present in NC-NA and CA, not in C-NA. There was a single
protein (uncharacterized protein) present only in NC-NA and C-NA, not in CA. To identify the
uncharacterized protein, a BLASTp was performed on two exclusive unique peptides which
consist of 48 amino acids. The non-redundant(nr) protein database at NCBI was queried. The very
top hit identified the estimated protein to be chicken immunoglobin heavy chain “IgH” protein.
The query coverage was 72%, and the identity was 98.02%. Four proteins (TF, TUBA1A1,
GSTA4L, F9) were induced in NC-NA vs. C-NA in response to the hypobaric challenge. In
addition, the level of immunoglobin heavy chain “IgH” declined below detectable in C-NA vs. CA
with the occurrence of ascites.
The quantitative proteomic profile and statistical analysis of the student T-test revealed that
131 proteins remained unchanged in NC-NA, relative to C-NA and in C-NA compared to CA (p<
0.05) (Table 3.1, Figure 3.3B). However, 9 proteins were significantly upregulated, and 8 proteins
were significantly downregulated in C-NA compared to CA in response to ascites. The following
proteins were found to be more abundant in the C-NA group when compared to the CA group (p<
0.05): apolipoprotein A-I (APOA1), ovotransferrin (TF), hemoglobin subunit beta (HBBA), beta2-glycoprotein 1 precursor (a protein induced by APOH gene), angiotensinogen (AGT),
peroxiredoxin-1 (PRDX1), calcium-binding protein (P22), prothrombin (F2), and coagulation
factor IX (F9). However, the abundance of other proteins including fibrinogen alpha chain (FGA),
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fibrinogen gamma chain precursor (FGG), fibrinogen beta chain (FGB), fibronectin (FN1), IgG
Fc-binding protein (FcγBP), complement factor H isoform X1 (produced by CFH gene),
glutathione peroxidase (GPX3) and von Willebrand factor precursor (VWF) was lower in C-NA
group compared to CA group (p<0.05) (Table 3.2).
Several biological processes and pathways were identified by uploading the gene ID
numbers of differentially expressed (upregulated/ downregulated) proteins to David Functional
Annotation Bioinformatics Microarray Analysis, PANTHERdb, and STRING. There are 27
various biological processes that are implicated in ascites development, one of which is shared by
upregulated and downregulated proteins (Figure 3.4). Among the listed biological process in
Figure 3.4, several biological processes were upregulated and downregulated to induce ascites,
such as acute phase response, blood coagulation, fibrinolysis, platelet activation, and platelet
aggregation.

The KEGG and Reactome pathways which initiate ascites are listed in Table 3.3.

There are three major pathways whose components are upregulated and four other pathways whose
components are downregulated. The most significant pathway is blood hemostasis, where a large
number of both upregulated and downregulated proteins are involved in the processes. Three
upregulated proteins; apolipoprotein A-I (APOA1), beta-2-glycoprotein 1 precursor (produced by
APOH gene), and ovotransferrin (TF), are responsible for platelet degranulation. Two upregulated
proteins belong to the intrinsic pathway, including prothrombin (F2) and coagulation factor IX
(F9). Moreover, these two proteins are involved in some metabolic processes, such as protein
metabolism. Five downregulated proteins; fibrinogen alpha chain (FGA), fibrinogen beta chain
(FGB), fibrinogen gamma chain precursor (FGG), fibronectin (FN1), and Von Willebrand factor
precursor (VWF), play an important role in platelet degranulation, initiating MAPK signaling
pathway, forming a fibrin clot, and serve as integrin signaling (Table 3.3). Figure 3.4 illustrates
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the number of upregulated and downregulated proteins that undergo various biological processes.
Protein-protein interactions were evaluated to have a better insight into how proteins are involved
in the protein network and initiate ascites. STRING database is an appropriate resource for
representing protein-protein interactions. Figure 3.5 shows the potential interactions between
upregulated and downregulated proteins using STRING.
Metabolomic Identification
The plasma samples from the same treatments (NC-NA, C-NA, CA) were used for
metabolomic studies to identify common and changed metabolites (total fatty acids, intact lipids,
small molecules). NC-NA was compared to C-NA to identify the significantly changed metabolites
in response to a hypobaric challenge, followed by another comparison between C-NA and CA to
determine the significantly changed metabolites in response to ascites.
Identification and Quantification of Total Fatty Acids
In our experiment, one step rapid method was performed using sodium methoxide (CH3
ONa) to hydrolyze any lipids to their fatty acid components and methylate for GC-MS studies.
This detects total fatty acid compositions in biological samples (Bielawska et al., 2010). Serum
total fatty acids profiles of NC-NA vs. C-NA and C-NA vs. CA are summarized in Table 3.4.
Saturated fatty acids (palmitic acid and stearic acid), monounsaturated fatty acids (palmitoleic acid
and oleic acid), and polyunsaturated fatty acids (linoleic acid) were identified in the broiler plasma.
There were no significant changes in fatty acids comparing NC-NA to C-NA. However, a
comparison of C-NA and CA showed that stearic acid (C18:0), oleic acid (C18:1), and linoleic
acid (C18:2) were significantly decreased with the onset of ascites. Palmitic acid and palmitoleic
acid were unchanged with the onset of ascites (Table 3.4). Both significant and non-significant
total fatty acids were eluted in the first 10 minutes (Figure 3.6).
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Identification and Quantification of the Intact Lipids in Broiler Plasma by LC-MS
An LC-MS method was used in this study to quantify the intact lipids in broiler plasma.
The major aim is to see the significantly changed lipids pre and post ascites development. To
study several lipid classes in broiler plasma, total lipids were extracted from six plasma samples
for each group (NC-NA, C-NA, CA) as described in the method section. Then, the samples were
analyzed by LC-MS in positive ion mode electrospray ionization (ESI). In the positive ion mode,
protonated lipid molecules[M+H] + were detected. Base peak chromatograms of the plasma extract
showed several visible peaks between the 0- and 40-minutes retention time (RT). However, most
of the significantly changed lipids eluted from 22 to 34 minutes RT. Mass spectra with relative
mass to charge ratio (m/z) from 723 to 846 correspond to different major putative lipid classes
(Table 3.5).
Using the LIPID MAPS, a total of 46 lipids were identified in all groups (NC-NA, C-NA,
CA) (Figure 3.7). Based on the quantitative comparison, 33 lipids remained unchanged in all
groups, whereas a comparison of NC-NA to C-NA showed significant downregulation of two
lipids (PC (36:1), and PC (40:0) in response to a hypobaric challenge. On the other hand, 11
upregulated and 2 downregulated lipids were identified in C-NA compared to CA with the onset
of ascites. The following lipids were found to be significantly higher in C-NA when compared to
CA [ phosphatidylcholine (PC) (34:2), PC (38:3), PC (38:1), PC (36:5), PC (36:3), PC (36:2), PC
(40:1), PC (36:1), PC (40:0), and cholesterol ester (CE) 16:1] (p<0.05). Only PC (36:4; O) was
significantly lower in C-NA compared to CA (Table 3.5, Figure 3.9).
The KEGG ID and HMD ID of total fatty acids and lipids were uploaded into the
MetaboAnalyst 5.0 system for visual and pathway analysis. Pathway enrichment analysis shows
that several biological pathways are associated with the upregulation and downregulation of fatty
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acids and lipids. These pathways include bile acid biosynthesis, alpha-linolenic acid, and linoleic
metabolism, plasmalogen synthesis pathway, biosynthesis of unsaturated fatty acids, arachidonic
acid metabolism, glycerophospholipids metabolism, steroid biosynthesis, and mitochondria betaoxidation of long-chain saturated fatty acids. Table 3.6 and Figure 3.10 summarize the major
biological pathways induced with ascites in broilers, including the pathway name, total fatty acids
and lipids involved in each pathway, total fatty acids and lipids significantly differentiated in this
study, p-value, false discovery rate (FDR), and KEGG and HMD ID for each pathway.
Identification and Quantification of Small Molecules
Further analytical studies were performed using an LC-MS/MS to see the significantly
changed small metabolites among the three groups (NC-NA, C-NA, CA). The obtained data “small
molecules data” was applied to fold change analysis for univariate evaluation. In volcano plots,
upregulated and downregulated small molecules were indicated by positive and negative values,
respectively (Figures 3.13 & 3.14). Fold changes were evaluated for statistically significant
changes based on the standard deviation of the fold change between groups. The volcano plot
verified highly differential small molecules (p<0.05) (Figures 3.13&3.14). Statistical analysis
showed that a total of 62 small molecules demonstrated a differential response. Out of these, 9
small molecules were classified as glycerophospholipids, a steroid hormone, dipeptide, and small
proteins (Figure 3.12). The Venn diagram shows the number of common and significantly changed
small molecules in NC-NA, C-NA, and CA. The overlapping section in the Venn diagram shows
a total of 104 small molecules that were common in all three groups (Figure 3.11). We did a mass
spec fragmentation to identify some of the most significant small molecules. Based on the
identified metabolites listed in Table 3.7, the following small molecules PE (18:2(9Z,12Z)/0:0),
PC (0:0/16:0), and PC (14:0/O-1:0) were significantly downregulated in NC-NA vs. C-NA in
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response to a hypobaric challenge. In contrast, several small molecules including PC
(18:2(9Z,12Z) \/0:0), PC (0:0/18:1(6Z), LysoPI(20:4(5Z,8Z,11Z,14Z)/0:0), PC (0:0/16:0), PE
(18:2(9Z,12Z)/0:0), and PC (14:0/O-1:0) were highly upregulated in C-NA compared to CA. Other
small molecules such as Ubiquitin, L-aspartyl-L-glutamate, and dehydroepiandrosterone sulfate
were highly downregulated in C-NA compared to CA. We only focused on identifying the
significantly changed (upregulated/ downregulated) small molecules related to C-NA vs. CA to
find a biomarker directly response to ascites in broiler chickens using several metabolic databases,
involving LIPIDS MAP, Human Metabolome Database (HMD), METLIN (Table 3.7).
The pathway analysis was done on significantly changed small molecules with low pvalues (Table 3.7) using Gallus gallus as the pathway database to connect their biological roles to
various signaling pathways. According to MetaboAnlyst 5.0 and KEGG, glycerophospholipids
metabolism, steroid hormone biosynthesis, and ribosome are three major pathways significantly
changed to induce the disease (Tables 3.8&3.9).

DISCUSSION
Fast-growing broilers (C-NA and CA) were raised in a hypobaric chamber to simulate the
high altitude (9000ft above sea level). Only the CA group developed ascites since they underwent
hypobaric hypoxia, where broilers increased their oxygen demand. As a result, the biological
system was stressed due to the lack of oxygen required for mitochondrial metabolism. Moreover,
proteins started to be modified by post-translation modifications or phosphorylation (Chandel et
al., 1996). Prolonged hypoxia caused alterations in gene expression, and it eventually led to cell
death once the adaptive mechanisms were depleted (Schumacker et al., 1993). The major aim of
this study was to find proteins and metabolites (total fatty acids, intact lipids, small molecules) in
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broiler plasma associated with ascites. This helped to identify several molecular biomarkers that
can differentiate the healthy birds from the affected ones.
Our results indicated that ascites developed because of upregulated and downregulated
proteins involved in various biological processes. The identified proteins were found to be
associated with different biological pathways, involving blood hemostasis, protein metabolism,
extracellular matrix interaction, focal adhesion, and signal transduction. Blood homeostasis is the
most significant pathway where both upregulated and downregulated proteins participate in the
interaction network.
The upregulation of hemostatic proteins such as apolipoprotein A-I (APOA1), beta-2glycoprotein 1 precursor, or apolipoprotein H (produced by APOH gene), ovotransferrin (TF),
prothrombin (F2), and coagulation factor IX (F9) disrupted the platelet degranulation and intrinsic
pathway. Apolipoprotein A-I (APOA1) is an interesting protein identified in C-NA compared to
CA. APOA1, a member of the APOA1/A4/E family, is produced mainly in the liver (Ahmad et
al., 2013). APOA1 is the primary functional and structural component of cholesterol or highdensity lipoprotein (HDL), being found in the extracellular space, and plays a significant role in
cholesterol hemostasis (Zhang et al., 2020). Several studies showed that APOA1 had
multifactional roles in apoptosis, immunity, and bacterial and viral infections (Mangaraj et al.,
2016). This protein is known as an inflammatory protein since it contributes to chronic and acute
inflammatory disorders (Zhang et al., 2020). APOA1 is also involved in decreasing the incidence
of cardiovascular diseases by removing fat particles (Di et al., 2016). It participates in protecting
the cardiovascular system because of its anti-aggregatory and anti-clotting effect on platelets
(Nkosi, 2019; Mangaraj et al., 2016). APOA1 protects the airway function and the pulmonary
artery along with preventing respiratory inflammation and collagen deposition (Wang et al., 2010).
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Plasma expression of APOA1 was significantly abundant (p-value <0.05) in C-NA compared to
CA, indicating the ant-inflammatory and anticoagulant roles of APOA1. This new finding was
confirmed by the high-altitude pulmonary edema (APE) in humans, which caused an upregulation
of APOA1 due to the inflammatory response (Ahmad et al., 2011). Therefore, APOA1 is classified
as an acute-phase protein (APP). Beta-2-glycoprotein 1 precursor or apolipoprotein H (APOH) is
another interesting APP protein whose expression was significantly abundant in the plasma from
C-NA compared to CA. APOH belongs to the family of complement control proteins (Erkan et al.,
2014). APOH is one of the most significant apolipoproteins which contributes to heart
development in fast-growing broilers. APOH binds and transfers lipids in blood circulation and
prevents the accumulation of triglycerides in the heart (Nielsen et al., 2002). Under severe
circumstances or diseases, APOH binds to the pathogen or its protein during the acute phase to
elicit an innate immunity response. (Stefas et al., 2011). In this study, APOH protein level was
highly upregulated (p<0.05) in C-NA vs. CA, supporting the anti-inflammatory response of
APOH. Another APP detected in C-NA vs. CA is ovotransferrin (TF). TF, which is a
transmembrane glycoprotein found in plasma and egg white, plays a critical role in ferric-ion
delivery and is responsible for iron metabolism (Giansanti et al., 2012). Several studies revealed
that TF serves as APP in broilers, and it increased under viral, chemical, and bacterial-induced
inflammation (Xie et al., 2002a; Xie et al., 2002b). Another study showed that the TF concentration
was altered under microbial and inflammatory stress. Thus, TF is a biomarker of inflammatory
and infectious diseases in broilers (Rath et al., 2009). In this study, TF was highly upregulated (pvalue <0.05) in C-NA relative to CA, supporting the potential anti-inflammatory role of TF. A
further interesting protein identified in C-NA compared to CA is prothrombin (F2). F2 is a plasma
protein synthesized in the liver, involved in blood clotting and maintaining normal hemostasis
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(Hoffman & Monroe, 2001). In previous studies, chickens with bacterial and fungal infections that
initiated inflammation would increase the expression of F2 (Roy et al., 2014). This happened due
to the defect in the common coagulation and intrinsic pathways. The higher expression of F2 is
associated with defective hepatic metabolism since this protein is a coagulation factor produced
by the liver (Fernandez et al., 1995). In the current study, the concentration of F2 was significantly
upregulated (p-value <0.05) in the plasma of C-NA compared to CA, suggesting the homeostatic
alterations as a part of an anti-inflammatory and pathophysiologic response to ascites.
Other upregulated proteins were identified in C-NA plasma and might be a biomarker for
ascites in fast-growing broilers. These proteins are hemoglobin subunit beta (HBBA),
angiotensinogen (AGT), peroxiredoxin-1 (PRDX1), and calcium-binding protein (P22).
Hemoglobin, which is an oxygen carrier and regulator component, is an iron-rich protein
distributed in all living organisms. This protein helps the organisms to adjust to different
environmental conditions (Melo et al., 2003). Previous studies proved that high expression of
hemoglobin might be linked to a hypoxic response since this protein is beneficial in providing the
tissues with oxygenated blood (Storz, 2007; Gordeuk et al., 2016). Hypoxic stress changes the
oxygen affinity and influences the oxygen transport properties of hemoglobin (Mairbäurl,1994).
The hemoglobin oxygen affinity allows for rapid alterations in oxygen binding and release.
Therefore, changes in the primary structure of the globin chain, which influence oxygen intake
and transport to tissues, are thought to be responsible for this adaption (Ahmad et al., 2013). In the
present study, the upregulation of hemoglobin subunit beta (HBBA) in C-NA compared to CA,
supports the potential role of HBBA in adapting to hypoxia. A further significant protein found in
C-NA vs. CA is angiotensinogen (AGT). The AGT, which is synthesized in the liver, is a
component of a hormonal system called the renin-angiotensin system (RAS). The RAS plays a
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significant role in regulating blood pressure and fluid balance (Wong, 2016). Several studies
showed a strong positive correlation between the plasma level of angiotensinogen and high blood
pressure in humans and mice (Walker et al., 1979; Kimura et al., 1992; Jeunemaitre et al., 1992).
Until now, AGT has not been reported as a plasma biomarker for PHS in broilers. Only one study
showed that brain AGT was overexpressed in broilers with PHS (Hassanpour et al., 2019). In the
current study, AGT was highly upregulated in C-NA, relative to CA, providing the primary
information for the possible effect of AGT in PHS in broilers. Plasma AGT could be a potential
molecular biomarker for the affected broilers, and this might be a new finding. Another interesting
protein identified in C-NA vs. CA is peroxiredoxin-1(PRDX1). PRDX1, which is a member of the
ubiquitous family (peroxiredoxin), is involved in regulating cellular redox homeostasis (Ding et
al., 2017). Based on physiological and pathophysiological studies, PRDX1 serves as a modulator
for cardiovascular events (Schroder et al., 2008; Jing et al., 2011; Guo et al., 2018). The high
expression level of this protein refers to cardiac hypertrophy, which causes pulmonary arterial
hypertension in mice (Tang et al., 2020). In this study, PRDX1 was significantly upregulated in
CA, supporting that PRDX1 induces right ventricular hypertrophy, which subsequently results in
a right-ventricular failure in broilers. PRDX1 might be a potential biomarker for PHS in chickens.
Another important protein detected in C-NA vs. CA is a calcium-binding protein (P22). The P22,
which is a member of the EF-hand superfamily, is a structural and functional protein of
sarcoplasmic and endoplasmic reticulum membranes (Milner et al., 1992; Barroso et al., 1996;
Andrade et al., 2004). Prolonged endoplasmic reticulum (ER) stress causes smooth muscle and
endothelial cell dysfunction. This results in inadequate vascular remodeling and intense pulmonary
vasoconstriction, which subsequently leads to pulmonary arterial hypertension in mice (Dromparis
et al., 2013; Hu et al., 2020; Pan et al., 2020; Pu et al., 2020). In this study, the P22 was highly
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upregulated in C-NA compared to CA. The high level of P22 in broiler plasma could result from
excessive ER stress and results in ascites development. The elevated level of this protein might be
a possible biomarker for ascites in broilers.
There are five downregulated acute phase proteins (APPs): fibrinogen alpha chain (FGA),
fibrinogen beta chain (FGB), fibrinogen gamma chain precursor (FGG), fibronectin (FN1), and
von Willebrand factor precursor (VWF) resulted in dysfunctioning of the hemostatic system. All
the first three proteins (FGA, FGB, FGG) were classified under the fibrinogen family, which is a
type of glycoprotein synthesized in the liver. The FGA binds to FGB and FGG to form fibrinogen
which plays a central role in coagulation or blood clot formation. Chickens infected with different
types of bacteria such as Streptococcus zooepidemicus, E. coli, and E. tenella stimulated
hyperfibrinogenemia as an acute phase response (infection-induced inflammatory) (Springer et al.,
1974; Georgieva et al., 2010; Roy et al., 2014). Similarly, humans and chicken fibrinogen
increased when exposed to stress (Lazzarino et al., 2015; Ellins et al., 2017; Nwaigwe et al., 2020).
Henderson et al. proved that the level of fibrinogen highly decreased in patients with ascites since
fibrinogen was degraded within the ascitic fluid (fibrinogenolysis) (1980). In the present study,
the three major types of fibrinogens (FGA, FGB, FGG) were significantly downregulated (pvalue<0.05) in the plasma of C-NA compared to CA, supporting the occurrence of fibrinogenolysis
in affected broilers. Therefore, fibrinogen might be a molecular biomarker for ascites in broilers.
Further work should be done on ascitic fluid to prove the previous statement. Fibronectin (FN1) is
a further hepatic glycoprotein, classified as extracellular matrix protein, and was identified in CNA compared to CA. The FN1 was highly expressed in patients with PHS since this protein is
involved in the proliferation of smooth muscle cells (Clausell & Rabinovitch, 1993; Jones et al.,
1997). Patients suffering from PHS exhibited overexpression of FN1 since FN1 is a major
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component in developing plexiform lesions (Tuder et al., 2007). Hamal et al. found that broilers
with idiopathic pulmonary arterial hypertension (IPAH) had a strong expression of FN1 in their
plasma due to the thickening of their pulmonary arterioles, and the proliferation of their smooth
muscle cells, and the formation of their plexiform lesions (2012). Changes in FN1 expression were
associated with the physiology and etiology of the disease. However, in our study, the level of FN1
was significantly downregulated (p-value<0.05) in C-NA compared to CA, suggesting that broilers
with PHS developed hepatic damage (Höfeler & Klingemann, 1984). Another downregulated
protein identified in C-NA vs. CA was the von Willebrand factor precursor (VWF). The VWF,
which is an adhesive glycoprotein, plays a significant role in hemostasis and thrombosis (Luo et
al., 2012). The VWF was reported to be a molecular biomarker of endothelial dysfunction since a
high level of this factor is present in atherosclerotic and inflammatory vascular disorders (Blann
& Lip, 1998). Patients with pulmonary hypertension are characterized by several
pathophysiological features, including a severe bleeding event (anticoagulation) (Opitz et al.,
2009). A low level of VWF has been linked to bleeding, especially in cardiovascular events
(Sadler, 2009; Roldán et al., 2011). In the current study, the VWF was highly downregulated (p
value<0.05) in C-NA relative to CA, supporting the idea of bleeding in the cardiovascular system
at the late stage of PHS.
There are other downregulated proteins identified in the broiler plasma and could be a
possible biomarker for ascites or pulmonary hypertension in broilers. These proteins are IgG Fcbinding protein (FcγBP), complement factor H isoform X1 (produced by CFH gene), and
glutathione peroxidase (GPX3). The IgG Fc-binding protein (FcγBP) is an interesting protein
detected in C-NA compared to CA. The FcγBP is produced by mucin-producing cells in different
mucosae, involving respiratory mucosa (Kobayashi et al., 2021). The FcγBP could be involved in
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the anti-inflammatory function and cell protection (Gazi et al., 2008). Airway obstruction can be
developed as a result of inflammation and mucus plugging (Fernandez-Bonetti et al., 1983). The
inflammatory response is a characteristic of pulmonary hypertension in broilers (Dorfmüller et al.,
2003; Low et al., 2015). However, the role of FcγBP in PHS is unknown. There is no specific
interpretation of why FcγBP was downregulated in C-NA vs. CA. This is a new finding and
potential biomarker which needs further work to be done for further confirmation. Another
important protein identified in C-NA vs. CA is complement factor H isoform X1(CFH). The CFH,
which is a glycoprotein, is essential in enhancing the defensive immune system by regulating
complement activation. Nevertheless, the dysregulation of the protective complement activation
might damage tissues, as proven in different ischemic, autoimmune, and inflammatory disorders
(Ricklin et al., 2016; Frid et al., 2020a). Previous studies unveiled the relative participation of
classic, alternative, and lectin activation pathways in the complement activation induced by tissue
remodeling and damage. The most important pathway is the activated alternative pathway which
regulates the pro-proliferative and proinflammatory alterations in the lung. A low level or absence
of CFH activated the complement alternative pathway involved in the PHS and its pathogenesis,
especially in affected individuals with high mortality risk (Rhodes et al., 2017; Li et al., 2019; Frid
et al., 2020b). In this study, the CFH was significantly downregulated in C-NA vs. CA, indicating
the activation of complement alternative pathways following the PHS induction. The last
significant protein detected in C-NA vs. CA is glutathione peroxidase (GPX3). The GPX3, which
is a cellular antioxidant enzyme, defense against oxidative stress by controlling the reactive oxygen
species (ROS) (Forgione et al., 2002; Blankenberg et al., 2003; Van, 2015). ROS leads to PHS
since it is an inflammatory mediator during hypoxia and ischemia. Furthermore, the ROS is
produced by activated macrophages as a result of cellular metabolism in the mitochondria and
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causes severe damage to the vascular endothelium of pulmonary blood vessels (Irodova et al.,
2002). A low level of GPX3 in the plasma was pronounced in individuals with PHS (Miyamoto et
al., 2003; Masri et al., 2008; Mikhael et al., 2019). In the current study, the GPX3 was highly
downregulated in C-NA compared to CA, supporting the central role of GPX3 in defending against
oxidative stress, which developed ascites in fast-growing broilers.
In the current study, we used targeted GC-MC metabolomics to examine the possibility of
plasma total fatty acids as a disease biomarker in broilers with ascites by comparing the results of
NC-NA to C-NA to CA. Our hypothesis was metabolites were highly differentiated in broilers
with PHS. A total of 6 total fatty acids were measured from different groups of broilers (NC-NA,
C-NA, CA). Then, the data were analyzed using different statistical analyses mentioned earlier.
We found that broilers from the C-NA group had a higher level of stearic acid (C18:0) and oleic
acid (C18:1) and a lower level of linoleic acid (C18:2) in a statistically significant way (Table 3.5)
when compared to the CA group. It has been reported that mitochondria functions are influenced
by different types of fatty acids. For instance, mitochondrial respiration and fatty acid
compositions are changed by different hormones (Clejan et al., 1980). Mitochondrial betaoxidation is a significant metabolic process that breaks down long-chain fatty acids and releases
energy in the form of ATP (Talley & Mohiuddin, 2021). The fatty acids can either be stored as
triglycerides or undergo beta-oxidation (Brittain et al., 2016). In PHS, either hypoxia, which
activates hypoxia-inducible factor 1-alpha (HIF-1 α), or oxidative stress, which results from
increasing the ROS and decreasing antioxidant enzymes, inhibits beta-oxidation of long-chain
fatty acids (Chen et al., 2020). That leads to massive accumulations of saturated and unsaturated
fatty acids (Huang et al., 2014; Chen et al., 2020). Furthermore, increasing the ROS was seen in
chickens with PHS (Cawthon et al., 2001). Therefore, chickens with PHS have different
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mitochondrial functions because of different fatty acid content or different ratio of saturated and
unsaturated fatty acids (Iqbal et al., 2002). Patients with hypertension showed a low level of
unsaturated fatty acids linoleic acid (C18:2) (Tsukamoto & Sugawara, 2018). Several studies
demonstrated an inverse relationship between linoleic acid and blood pressure (Wang et al., 2008;
Wang et al., 2011; Zeng et al., 2014). A high level of linoleic acid may induce relaxation in the
coronary artery in pigs and acts as a substrate for vasoactive prostaglandins in mice (Iacono &
Dougherty, 1993; Pomposiello et al., 1998). In our study, the level of saturated and unsaturated
fatty acids s such as stearic acid (C18:0) and oleic acid (C18:1) was significantly increased in CNA relative to CA, indicating that broilers with PHS had different mitochondrial functions. They
underwent beta-oxidation, which triggered the accumulation of these two fatty acids. On the other
hand, linoleic acid was highly downregulated in C-NA vs. CA, which initiates hypertension.
The LC-MS and LC-MS/MS metabolomics were used to identify potential plasma intact
lipids and small molecules as a molecular biomarker for PHS in fast-growing broilers. Novelty,
the present study demonstrated different glycerophospholipids [phosphatidylcholine (PC) and
phosphatidylethanolamine (PE)], lysophosphatidylinositols (LysoPIs), and a sterol lipid [
cholesterol esters (CE)] profile changes in C-NA, relative to CA. Emerging literature indicated
that higher levels of plasma total fatty acids and lower levels of high-density lipoprotein
cholesterol could elicit an abnormal metabolization of the lipids in patients with PHS. That leads
to elevate lipid deposition in the cardiomyocytes of the right ventricle (RV), RV lipotoxicity, and
RV hypertrophy (Heresi et al., 2010; Hemnes et al., 2014; Talati & Hemnes, 2015; Brittain et al.,
2016; Hemnes et al., 2019). Our results agree with the previous study since saturated fatty acids
(stearic acid) and unsaturated fatty acids (oleic acid) were significantly increased in C-NA vs. CA
(p<0.05). Therefore, the following lipids: PC (34:2), PC (38:3), PC (38:1), PC (36:5), PC (36:3),
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PC (36:2), PC (40:1), PC (36:1), PC (40:0), CE 16:1, PC (18:2(9Z,12Z) \/0:0), PC (0:0/18:1(6Z),
LysoPI(20:4(5Z,8Z,11Z,14Z)/0:0), PC (0:0/16:0), PE (18:2(9Z,12Z)/0:0), and PC (14:0/O-1:0)
were statistically significant abundant in C-NA relative to CA (p<0.05). In addition, our
metabolomic analysis showed a possible new finding. Among the most significantly changed
metabolites, one phosphatidylcholine PC (36:4; O) was significantly lower in C-NA compared to
CA. This could be a possible association with PHS since the PC is the main phospholipid that
provides the endothelial cells with arachidonic acid (Thomas et al., 1984). Prostacyclin, which is
produced by arachidonic acid metabolism from the vascular wall, is a potent vasodilator. In
patients with PHS, an imbalance of prostacyclin production reflects the activation of platelets and
induces an abnormal reaction of the pulmonary endothelium (Christman et al., 1992).
There are other small metabolites identified in the plasma of C-NA vs. CA using LCMS/MS. One of the most important small metabolites is ubiquitin. Ubiquitin, which is a small
protein (76 amino acids), plays a central role in targeting protein for proteasomal degradation by
a process known as the ubiquitin-proteasome system (UPS) (Rathinasabapathy & West, 2018;
Wade et al., 2018). The pro-inflammatory response in the late stage of PHS activates several
transcription factors, one of which is nuclear factor kappa B (NF-κB). The NF-κB is mainly
activated in pulmonary vascular cells, lymphocytes, and macrophages ((Price et al., 2013). The
activation of NF-κB is associated with vascular remodeling and cardiovascular hypertrophy
(Zhang et al., 2014). Similarly, the UPS plays a significant role in PHS development because it is
involved in pulmonary vascular remodeling (Wade et al., 2018). Previous studies demonstrated a
strong positive relationship between UPS and NF-κB pathway in PHS (Zhang et al., 2014).
Another study proved that the level of total ubiquitin increased in patients with hypertrophic
cardiopathy, indicating that the UPS is dysfunctional, and the total protein degradations are
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decreased in heart failure (Zolk et al., 2006). On the other hand, Wade et al. demonstrated that
patients with PHS showed a reduction in the net ubiquitin involved in protein degradation due to
the development of hypoxia (2018). In this study, the ubiquitin was significantly downregulated
in the C-NA, suggesting the adaptive response of ubiquitin in broilers with PHS against hypoxia.
Another important metabolite identified in the plasma is dehydroepiandrosterone sulfate (DHEAS). DHEA-S is a male sex hormone expressed in both genders. It is responsible for the production
of male and female sex hormones (testosterone and estrogen) (Webb et al., 2006). DHEA-S assists
in controlling the blood pressure and heart rate in humans (Schunkert et al., 1999). This hormone
plays a significant role in stress response, especially in domestic animals and humans (Gabai et
al., 2020). Several studies proved that a reduced level of DHEA-S is associated with PHS in
humans and mice (Hampl et al., 2003; Ventetuolo et al., 2016; Baird et al., 2018). In addition,
DHEA-S was used as a pharmacological drug to minimize chronic hypoxia that induces pulmonary
hypertension in mice (Hampl et al., 2003). In our study, DHEA-S was significantly downregulated
in C-NA compared to CA. DHEA-S could be a potential biomarker for PHS in broilers.
In conclusion, our data revealed that there were significant changes in proteomes and
metabolomes (fatty acids, lipids, small molecules) in the C-NA group relative to the CA group due
to anti-inflammatory, pathophysiologic, hypoxia, and oxidative stress- responses which develop
ascites. We were able to identify some molecular biomarkers similar to what has been published
so far. Furthermore, many of the identified biomarkers are new findings that need further work to
be proved. The candidate biomarkers might give some explanations of how the ascites developed
in chickens. These new biomarkers could be a beneficial tool for early ascites detection.
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TABLES AND FIGURES
Table 3. 1. The common unchanged proteins in NC-NA relative to C-NA and C-NA relative to CA.
Protein #
Accession Number Gene Name
Identified Proteins

130

1
2

A0A1D5NW68
F1NK40

ALB
A2ML4

3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

A0A1D5P9F9 (+1)
Q197X2
F1NV02
Q90633
P02112
P02789
Q4ADJ6
Q4ADG4
A0A1D5NVI0
A0A1D5PCD2
P01994
A0A1D5P6F4
A0A1D5PU94
P02001
F1NMZ3 (+1)
A0A1L1S0P1
E1C7A7 (+1)
O93601

C3
APOB
APOB
HBB
TFEW
TFEW
HBBA
HBAA
C4A
HBAD
HBBR
PIT54
VTN
APOAIV

Serum albumin OS=Gallus gallus OX=9031 GN=ALB PE=4 SV=1
Alpha-2-macroglobulin-like protein 1 OS=Gallus gallus OX=9031 GN=A2ML4 PE=4
SV=4
Complement C3 precursor OS=Gallus gallus OX=9031 GN=C3 PE=4 SV=1
Apolipoprotein B OS=Gallus gallus OX=9031 GN=APOB PE=2 SV=1
Apolipoprotein B OS=Gallus gallus OX=9031 GN=APOB PE=4 SV=2
Complement C3 OS=Gallus gallus OX=9031 PE=2 SV=1
Hemoglobin subunit beta OS=Gallus gallus OX=9031 GN=HBB PE=1 SV=2
Ovotransferrin OS=Gallus gallus OX=9031 PE=1 SV=2
Ovotransferrin OS=Gallus gallus OX=9031 GN=TFEW PE=2 SV=1
Ovotransferrin OS=Gallus gallus OX=9031 GN=TFEW PE=2 SV=1
Hemoglobin subunit beta OS=Gallus gallus OX=9031 GN=HBBA PE=3 SV=1
Alpha-2-macroglobulin isoform X2 OS=Gallus gallus OX=9031 PE=4 SV=2
Hemoglobin subunit alpha-A OS=Gallus gallus OX=9031 GN=HBAA PE=1 SV=2
IgGFc-binding protein OS=Gallus gallus OX=9031 PE=4 SV=1
Complement C4 OS=Gallus gallus OX=9031 GN=C4A PE=4 SV=1
Hemoglobin subunit alpha-D OS=Gallus gallus OX=9031 GN=HBAD PE=1 SV=1
Hemoglobin subunit epsilon OS=Gallus gallus OX=9031 GN=HBBR PE=3 SV=1
PIT54 protein precursor OS=Gallus gallus OX=9031 GN=PIT54 PE=4 SV=1
vitronectin precursor OS=Gallus gallus OX=9031 GN=VTN PE=4 SV=2
Apolipoprotein AIV OS=Gallus gallus OX=9031 GN=apoAIV PE=2 SV=1

Table 3.1. Continued.
Protein #
Accession Number

Gene Name
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21

F1NEQ4

A2ML2

22

R9PXM5

IGLL1

23
24
25

F1NWX6
PLG
A0A1D5PD98
C5
A0A1D5NXA6 (+1) ITIH3

26
27
28
29
30
31
32

E1BZE1
A0A1I7Q422 (+1)
A0A1D5P1E3 (+1)
F1NTM6
O93510
P01875
F1NVF3

AHSG
TTR

33

B3VE14

ITIH2

34
35

A0A1D5P5V5
A0A1D5PV66

C4
LOC100857892

36

A0A1D5PLZ2 (+1)

SERPIND1

37

Q5ZHM4

RCJMB04_35g11

38
39

F1NA58
A0A146F050

KRT6A

TFR2
GSN
GC

Identified Proteins
Alpha-2-macroglobulin isoform X2 OS=Gallus gallus OX=9031 GN=A2ML2
PE=4 SV=4
Ig lambda chain V-1 region precursor OS=Gallus gallus OX=9031 GN=IGLL1
PE=4 SV=2
Plasminogen OS=Gallus gallus OX=9031 GN=PLG PE=3 SV=2
Complement C5 OS=Gallus gallus OX=9031 GN=C5 PE=4 SV=1
Inter-alpha-trypsin inhibitor heavy chain 3 OS=Gallus gallus OX=9031 GN=ITIH3
PE=4 SV=1
Alpha 2-HS glycoprotein OS=Gallus gallus OX=9031 GN=AHSG PE=4 SV=1
Transthyretin OS=Gallus gallus OX=9031 GN=TTR PE=3 SV=1
Alpha-2-macroglobulin isoform X2 OS=Gallus gallus OX=9031 PE=4 SV=1
Transferrin receptor protein 1 OS=Gallus gallus OX=9031 GN=TFR2 PE=4 SV=3
Gelsolin OS=Gallus gallus OX=9031 GN=GSN PE=2 SV=1
Ig mu chain C region OS=Gallus gallus OX=9031 PE=2 SV=2
Vitamin D-binding protein precursor OS=Gallus gallus OX=9031 GN=GC PE=4
SV=1
Inter-alpha inhibitor heavy chain 2 OS=Gallus gallus OX=9031 GN=ITIH2 PE=2
SV=1
complement 4 precursor OS=Gallus gallus OX=9031 GN=C4 PE=4 SV=1
Alpha-tectorin protein OS=Gallus gallus OX=9031 GN=LOC100857892 PE=4
SV=1
Serpin family D member 1 OS=Gallus gallus OX=9031 GN=SERPIND1 PE=3
SV=1
Hypothetical protein RCJMB04_35g11 OS=Gallus gallus OX=9031
GN=RCJMB04_35g11 PE=2 SV=1
Serpin family G member 1 OS=Gallus gallus OX=9031 PE=3 SV=3
Type II alpha-keratin IIC OS=Gallus gallus OX=9031 GN=KRT6A PE=2 SV=1

Table 3.1. Continued
Protein #

Accession Number

Gene Name
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40

E1C7T1

SPIA1

41
42

P10184
F1P2M6

OIH
LOC419851

43
44
45
46
47
48
49

Q5ZMQ2
A0A1D5PEY8
E1C6U2 (+1)
A0A1L1RKA9 (+1)
A2N883
A0A160F7C1 (+1)
Q7LZS1

ACTG1

50
51
52
53
54

H9L385
A0A1D5PV72
A0A1L1RNR4
A0A1D5P3R2 (+1)
E1C7C1

HPX

55
56

F1NJU5
E1BY93

C8A
JCHAIN

57
58
59

P41263
A0A1D5NTU8
P01038 (+1)

RBP4

C7
HRG
VH1

KNG1
CA2
C8B

Identified Proteins
Alpha-1-antitrypsin isoform X1 OS=Gallus gallus OX=9031 GN=SPIA1 PE=3
SV=1
Ovoinhibitor OS=Gallus gallus OX=9031 GN=OIH PE=1 SV=2
Complement component 4 binding protein, GPI-anchored precursor OS=Gallus
gallus OX=9031 GN=LOC419851 PE=4 SV=1
Actin, cytoplasmic 2 OS=Gallus gallus OX=9031 GN=ACTG1 PE=1 SV=1
Complement C8 gamma chain OS=Gallus gallus OX=9031 PE=3 SV=1
Complement component 7 OS=Gallus gallus OX=9031 GN=C7 PE=4 SV=2
Histidine rich glycoprotein OS=Gallus gallus OX=9031 GN=HRG PE=4 SV=1
VH1 protein (Fragment) OS=Gallus gallus OX=9031 GN=VH1 PE=2 SV=1
Corticosteroid binding globulin OS=Gallus gallus OX=9031 PE=2 SV=1
12K serum protein, beta-2-m cross-reactive (Fragment) OS=Gallus gallus OX=9031
PE=1 SV=1
Hemopexin OS=Gallus gallus OX=9031 GN=HPX PE=4 SV=3
Immunoglobulin heavy chain OS=Gallus gallus OX=9031 PE=4 SV=1
Kininogen 1 OS=Gallus gallus OX=9031 GN=KNG1 PE=4 SV=1
Carbonic anhydrase 2 OS=Gallus gallus OX=9031 GN=CA2 PE=4 SV=1
Complement component C8 beta chain precursor OS=Gallus gallus OX=9031
GN=C8B PE=4 SV=2
Complement C8 alpha chain OS=Gallus gallus OX=9031 GN=C8A PE=4 SV=2
Immunoglobulin J chain precursor OS=Gallus gallus OX=9031 GN=JCHAIN PE=4
SV=1
Retinol-binding protein 4 OS=Gallus gallus OX=9031 GN=RBP4 PE=1 SV=1
Uncharacterized protein OS=Gallus gallus OX=9031 PE=3 SV=1
Cystatin OS=Gallus gallus OX=9031 PE=1 SV=2

Table 3.1. Continued
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Protein #
60
61
62
63
64
65
66

Accession Number
SERPINC1
F1NSC8
A0A1D5PMQ5
F1NDN6
Q90W37
A0A1D5NW11 (+2)
P81475

Gene Name
F1NLP7
IGLL1
KRTC42L

67
68
69
70
71
72
73
74
75
76
77

A0A1D5NTE9
B8ZX71
A0A1D5PU00
A0A1D5PAQ0
A0A1D5PBP6
Q9W6U9
E1BZN8
A0A1L1RK76
A0A1D5PW77
A7UEB0 (+1)
Q90933

CFD
C6
AMBP

78
79

F1NSC7
F1NHT5

COL2A1
KRT19

CP
gp130
HGFAC
TUBA1A1
LOC776376
OGCHI

FETUB

Identified Proteins
Antithrombin-III OS=Gallus gallus OX=9031 GN=SERPINC1 PE=3 SV=2
IgL OS=Gallus gallus OX=9031 GN=IGLL1 PE=4 SV=4
Uncharacterized protein OS=Gallus gallus OX=9031 GN=KRTC42L PE=3 SV=2
Keratin 12 OS=Gallus gallus OX=9031 PE=3 SV=3
Alpha 1 type IIA collagen OS=Gallus gallus OX=9031 GN=COL2A1 PE=2 SV=1
Keratin, type I cytoskeletal 19 OS=Gallus gallus OX=9031 GN=KRT19 PE=3 SV=1
Complement factor B-like protease (Fragment) OS=Gallus gallus OX=9031 PE=1
SV=1
Complement factor D OS=Gallus gallus OX=9031 GN=CFD PE=3 SV=1
Complement C6 OS=Gallus gallus OX=9031 GN=C6 PE=2 SV=1
Protein AMBP precursor OS=Gallus gallus OX=9031 GN=AMBP PE=4 SV=1
Immunoglobulin heavy chain OS=Gallus gallus OX=9031 PE=4 SV=1
Ceruloplasmin OS=Gallus gallus OX=9031 GN=CP PE=3 SV=1
Glycoprotein 130 OS=Gallus gallus OX=9031 GN=gp130 PE=2 SV=1
HGF activator OS=Gallus gallus OX=9031 GN=HGFAC PE=3 SV=2
Tubulin alpha chain OS=Gallus gallus OX=9031 GN=TUBA1A1 PE=3 SV=1
C-reactive protein OS=Gallus gallus OX=9031 GN=LOC776376 PE=4 SV=1
Alpha-1-acid glycoprotein OS=Gallus gallus OX=9031 GN=OGCHI PE=2 SV=1
Neuron-glia cell adhesion molecule (Ng-CAM) OS=Gallus gallus OX=9031 PE=2
SV=1
Immunoglobulin lambda light chain OS=Gallus gallus OX=9031 PE=4 SV=3
Fetuin-b precursor OS=Gallus gallus OX=9031 GN=FETUB PE=4 SV=2

Table 3.1. Continued
Protein #

Accession Number

Gene Name
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80
81
82
83
84
85
86
87

F1P4N9
P62801 (+1)
E1C7H6
A0A1D5PRS4 (+1)
P02457
A0A0K0PUH6
F1P4U3
P00337

POSTN
H4-I
SERPINF1
GPI
COL1A1
RARRES2
SPP2
LDHB

88
89
90
91

Q9YGP0
E1BSP0
E1BWI0
A0A1L1RPW4 (+1)

C1QA
DSP
COL12A1

92
93

F1NQ20 (+1)
E1BWG1

COL9A1
F13A1

94

A0A1D5NW85 (+1) EXFABP

95
96
97

A0A1D5PGB2
F1N9H4
F1NAR5

COL11A2
EEF1A2

Identified Proteins
Periostin precursor OS=Gallus gallus OX=9031 GN=POSTN PE=4 SV=1
Histone H4 OS=Gallus gallus OX=9031 GN=H4-I PE=1 SV=2
Serpin family F member 1 OS=Gallus gallus OX=9031 GN=SERPINF1 PE=3 SV=2
Glucose-6-phosphate isomerase OS=Gallus gallus OX=9031 GN=GPI PE=3 SV=1
Collagen alpha-1(I) chain OS=Gallus gallus OX=9031 GN=COL1A1 PE=1 SV=3
Chemerin OS=Gallus gallus OX=9031 GN=RARRES2 PE=2 SV=1
Secreted phosphoprotein 24 OS=Gallus gallus OX=9031 GN=SPP2 PE=4 SV=3
L-lactate dehydrogenase B chain OS=Gallus gallus OX=9031 GN=LDHB PE=1
SV=3
Clusterin OS=Gallus gallus OX=9031 PE=2 SV=1
Complement C1q A chain OS=Gallus gallus OX=9031 GN=C1QA PE=4 SV=2
Desmoplakin OS=Gallus gallus OX=9031 GN=DSP PE=4 SV=4
Collagen alpha-1(XII) chain OS=Gallus gallus OX=9031 GN=COL12A1 PE=4
SV=1
Collagen alpha-1(IX) chain OS=Gallus gallus OX=9031 GN=COL9A1 PE=4 SV=2
Coagulation factor XIII A chain OS=Gallus gallus OX=9031 GN=F13A1 PE=4
SV=2
Extracellular fatty acid-binding protein OS=Gallus gallus OX=9031 GN=EXFABP
PE=3 SV=1
Complement C1q C chain OS=Gallus gallus OX=9031 GN=COL11A2 PE=4 SV=1
Elongation factor 1-alpha OS=Gallus gallus OX=9031 GN=EEF1A2 PE=3 SV=3
Serpin family F member 2 OS=Gallus gallus OX=9031 PE=3 SV=2

Table 3.1. Continued
Protein #

Accession Number

Gene Name
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98

Q9W6J2

GSTA4L

99

A0A1D5P140

SPEN

100
101

A0A1D5P5L2
A0A346RQZ3 (+2)

F5
HSP70

102
103
104
105
106
107

F1N9S7 (+1)
E1C206
A0A1L1RNY8
A0A1D5PC92
A0A1D5P0Y6 (+1)
A0A1D5P9K1

ANXA1
SPIA5
H2AFX
HIST1H2B5L
DST

108
109

P11533
DMD
A0A1D5NW25 (+1) VPS13D

110
111
112
113

A0A1D5P1M0
Q90824
G1K338
A0A1D5NY79

MYH11

114
115

A0A1D5PC18 (+2)
E1BZI5 (+1)

H3F3C
SYNE2

TUBB2B
RAB12

Identified Proteins
Glutathione S-transferase class-alpha OS=Gallus gallus OX=9031 GN=GSTA4L
PE=2 SV=1
Spen family transcriptional repressor OS=Gallus gallus OX=9031 GN=SPEN PE=4
SV=1
Coagulation factor V OS=Gallus gallus OX=9031 GN=F5 PE=3 SV=2
Heat shock protein 70 OS=Gallus gallus OX=9031 GN=HSP70 PE=3 SV=1
Annexin OS=Gallus gallus OX=9031 GN=ANXA1 PE=3 SV=1
Alpha-1-antitrypsin isoform X1OS=Gallus gallus OX=9031 GN=SPIA5 PE=3 SV=3
Histone H2A OS=Gallus gallus OX=9031 GN=H2AFX PE=3 SV=1
Histone H2B OS=Gallus gallus OX=9031 GN=HIST1H2B5L PE=3 SV=1
Dystonin OS=Gallus gallus OX=9031 GN=DST PE=4 SV=1
Obscurin, cytoskeletal calmodulin and titin interacting RhoGEF OS=Gallus gallus
OX=9031 PE=4 SV=2
Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1
Vacuolar protein sorting 13 homolog D OS=Gallus gallus OX=9031 GN=VPS13D
PE=4 SV=1
Myosin-11 OS=Gallus gallus OX=9031 GN=MYH11 PE=3 SV=1
Cytotactin 200kD OS=Gallus gallus OX=9031 PE=2 SV=1
Tubulin beta chain OS=Gallus gallus OX=9031 GN=TUBB2B PE=3 SV=2
RAB12, member RAS oncogene family OS=Gallus gallus OX=9031 GN=RAB12
PE=4 SV=1
Histone H3 OS=Gallus gallus OX=9031 GN=H3F3C PE=3 SV=1
Spectrin repeat containing nuclear envelope protein 2 OS=Gallus gallus OX=9031
GN=SYNE2 PE=4 SV=3

Table 3.1. Continued
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Protein #

Accession Number

Gene Name

Identified Proteins

116
117

F1NLS8
R4GJN9

TTBK1
ETAA1

118
119

P13648
Q04619

LMNA
HSP90AB1

120
121
122
123
124

A0A1D5PY99 (+2) NME2
F1P1U0
A0A1D5PEM3 (+1) SYNE1
F1NLZ9
A0A1D5PDR9 (+1) DYNC2H1

125

A0A1D5PAH0

MYCBP2

126
127

A0A1D5PX29
F1NKL4

UTRN
DYNC1H1

128

A0A1D5P1G1 (+2)

SASH1

129

F1NGU3

LRPPRC

130
131

F1NHM9 (+1)
P54939 (+2)

PGAM1
TLN1

Tau-tubulin kinase 1 OS=Gallus gallus OX=9031 GN=TTBK1 PE=4 SV=2
ETAA1, ATR kinase activator OS=Gallus gallus OX=9031 GN=ETAA1 PE=4
SV=2
Lamin-A OS=Gallus gallus OX=9031 GN=LMNA PE=2 SV=1
Heat shock cognate protein HSP 90-beta OS=Gallus gallus OX=9031
GN=HSP90AB1 PE=2 SV=1
Nucleoside diphosphate kinase OS=Gallus gallus OX=9031 GN=NME2 PE=3 SV=1
Dynein axonemal heavy chain 8 OS=Gallus gallus OX=9031 PE=4 SV=3
Nesprin-1OS=Gallus gallus OX=9031 GN=SYNE1 PE=4 SV=1
Ryanodine receptor 2 OS=Gallus gallus OX=9031 PE=4 SV=3
Dynein cytoplasmic 2 heavy chain 1 OS=Gallus gallus OX=9031 GN=DYNC2H1
PE=4 SV=1
MYC binding protein 2, E3 ubiquitin protein ligase OS=Gallus gallus OX=9031
GN=MYCBP2 PE=4 SV=1
Utrophin OS=Gallus gallus OX=9031 GN=UTRN PE=4 SV=1
Dynein cytoplasmic 1 heavy chain 1 OS=Gallus gallus OX=9031 GN=DYNC1H1
PE=4 SV=3
SAM and SH3 domain containing 1 OS=Gallus gallus OX=9031 GN=SASH1 PE=4
SV=1
Leucine rich pentatricopeptide repeat containing OS=Gallus gallus OX=9031
GN=LRPPRC PE=4 SV=2
Phosphoglycerate mutase OS=Gallus gallus OX=9031 GN=PGAM1 PE=3 SV=3
Talin-1 OS=Gallus gallus OX=9031 GN=TLN1 PE=1 SV=2
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↑↓

Log Fold
Change

Identified Proteins

Molecular
Weight

APOA1

T-Test (pvalue): (p
< 0.05)
0.021

↑

0.7

32kDa

TF
FGA

0.013
0.0011

↑
↓

2.2
0.09

Q90864
E1BV78

HBBA
FGG

0.048
0.00010

↑
↓

0.2
0.06

F1NUL9 (+1)

FGB

0.00014

↓

0.05

F1NJT4
E1C7P4

FN1
CFH

0.036
0.015

↓
↓

0.8
0.6

F1NPJ8

GPX3

0.02

↓

0.4

APOH

0.003
0.0078

↓
↑

0.2
2.0

AGT
VWF

0.01
0.00015

↑
↓

4.4
0.07

PRDX1
P22

0.022
0.034

↑
↑

16
6

Apolipoprotein A-I OS=Gallus gallus OX=9031 GN=APOA1 PE=3
SV=1
Ovotransferrin OS=Gallus gallus OX=9031 GN=TF PE=3 SV=1
Fibrinogen alpha chain OS=Gallus gallus OX=9031 GN=FGA PE=4
SV=2
Beta-H globin OS=Gallus gallus OX=9031 GN=HBBA PE=3 SV=1
Fibrinogen gamma chain precursor OS=Gallus gallus OX=9031
GN=FGG PE=4 SV=2
Fibrinogen beta chain OS=Gallus gallus OX=9031 GN=FGB PE=4
SV=2
Fibronectin OS=Gallus gallus OX=9031 GN=FN1 PE=4 SV=3
Complement factor H isoform X1 OS=Gallus gallus OX=9031
GN=CFH PE=4 SV=2
Glutathione peroxidase OS=Gallus gallus OX=9031 GN=GPX3 PE=3
SV=2
IgGFc-binding protein OS=Gallus gallus OX=9031 PE=4 SV=1
Beta-2-glycoprotein 1 precursor OS=Gallus gallus OX=9031
GN=APOH PE=4 SV=1
Angiotensinogen OS=Gallus gallus OX=9031 GN=AGT PE=3 SV=2
Von Willebrand factor precursor OS=Gallus gallus OX=9031 GN=VWF
PE=4 SV=1
Peroxiredoxin-1 OS=Gallus gallus OX=9031 GN=PRDX1 PE=1 SV=1
Calcium-binding protein OS=Gallus gallus OX=9031 GN=P22 PE=2
SV=1
Prothrombin OS=Gallus gallus OX=9031 GN=F2 PE=3 SV=1

Accession
Number

Gene
Name

A0A1L1RJF5
(+1)
A0A1D5P4L7
F1P4V1

A0A1D5PS90
A0A1D5PNU2
F1NDH2
A0A1D5PLV4
(+3)
P0CB50
Q90940

78kDa
87kDa
16kDa
50kDa
55kDa
272kDa
148kDa
24kDa
23kDa
41kDa
51kDa
306kDa
22kDa
22kDa

A0A1L1RV31
F2
0.013
↑
7
69kDa
(+2)
F1NWP1
F9
0.016
↑
0
Coagulation factor IX OS=Gallus gallus OX=9031 GN=F9 PE=3 SV=1
52kDa
Table 3. 2. Differentially expressed proteins found in C-NA relative to CA. The table includes the accession number, gene name, T-test, or pvalue (p-value <0.05), the up (↑) and down (↓) arrows (the up arrow (↑) is the upregulated proteins in the C-NA relative to the CA, while the down
arrow (↓) is the downregulated proteins in the C-NA relative to the CA), the fold change, the protein name, and the molecular weight.

Table 3. 3.KEGG and Reactome pathways enrichment analysis. Each biological pathway has a KEGG or Reactome ID number, does different
functions, and is affected by a number of upregulated and downregulated proteins (count in gene set)
NO.

PATHWAY ID

PATHWAY NAME

Upregulated pathways
1
R-GGA-114608
2
R-GGA-159763

Hemostasis
Metabolism of proteins

3

Metabolism of proteins

R-GGA-159782
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4
R-GGA-140837
Downregulated pathways
1
Gga04512
2
Gga04510
3
R-GGA-354194
4

R-GGA-354194

5
6
7
8
9
10
11

R-GGA-372708
R-GGA-372708
R-GGA-354192
R-GGA-354192
R-GGA-216083
R-GGA-114608
R-GGA-140875

Hemostasis
ECM-receptor interaction
Focal adhesion
Hemostasis

BIOLOGICAL PROCESS OR MAJOR
FUNCTIONS

Platelet degranulation
Transport of gamma-carboxylated protein precursors
from the endoplasmic to the Gologi apparatus
Removal of amino terminal peptides from gammacarboxylated proteins
Intrinsic pathway of fibrin clot formation

GRB2: SOS provides linkage to MAPK signaling for
integrins
Singal transduction
GRB2: SOS provides linkage to MAPK signaling for
integrins
Hemostasis
P 130Cas linkage to MAPK signaling for integrins
Singal transduction
P 130Cas linkage to MAPK signaling for integrins
Hemostasis
Integrin signaling
Singal transduction
Integrin signaling
Extracellular matrix interactions Integrin cell surface interactions
Hemostasis
Platelet degranulation
Hemostasis
Common pathway of fibrin clot formation

COUNT
IN
GENE
SET
3
2
2
2
2
2
5
5
5
5
5
5
5
5
3

Table 3. 4.Free fatty acids of broiler plasma from NC-NA, C-NA, and CA. Values with the red color
show significantly changed free fatty acids in C-NA, relative to CA (p<0.05). The up arrow (↑) is the
upregulated fatty acids in the C-NA relative to the CA, while the down arrow (↓) is the downregulated fatty
acids in the C-NA relative to the CA. NC means no significant changes
Retention
time (RT)
(min)

p-value (NC-NA
vs C-NA)

p-value (C-NA
vs CA)

Free fatty acids
(FFA)

Change trend (↑↓)
C-NA vs CA

6.5

0.32

0.21

Palmitic acid
(C16:0)

NC

6.7

0.16

0.18

Palmitoleic acid
(C16:1)

NC

7.9

0.53

0.02

8.2

0.82

0.03

8.7

0.39

0.02

Stearic acid
(C18:0)
Oleic acid
(C18:1)
Linoleic acid
(C18:2)

11.3

0.77

0.85

↑
↑
↓
NC

Abbreviation: NC-NA= non challenge / no ascites, C-NA= challenge without ascites, CA= challenge
with ascites, FC= no significant change.
.
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Table 3. 5.Possible peak lists with their mass to charge ratio (m/z) and corresponding [M+H] + peak for 13 lipids. Values with the red color
show significant differentiation of the listed lipids (p<0.05). The up arrow (↑) is the upregulated lipids in the C-NA relative to the CA, while the
down arrow (↓) is the downregulated lipids in the NC-NA vs. C-NA and C-NA vs. CA
Retention
time (RT)
(min)

m/z

22.483
23.9
22.525

758.573
812.614
816.622

22.4

p-values
(NC-NA
vs C-NA)
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FC (NCNA vs CNA)

p-values
(C-NA vs
CA)

FC (CNA vs
CA

0.26
0.13
0.045

3.65
3.17
3.32

0.006
0.004
0.005

0.41
0.39
0.31

780.557

0.48

3.29

0.010

0.30

22.519

784.589

0.22

3.29

0.005

0.35

23.312

786.606

0.40

3.72

0.04

0.51

23.323

798.545

0.40

2.6

0.015

1.06

23.489

844.654

0.17

3.60

0.02

0.48

23.708
24.522

824.599
788.618

0.36
0.017

2.63
3.05

0.03
0.023

0.98
0.48

24.616

846.674

0.011

2.86

0.016

0.39

26.8

623.621

1.53

0.17

0.006

0.23

33.947

723.64

0.28

2.67

0.001

0.34

Lipids

PC (34:2) [M+H] +
PC (38:3) [M+H] +
PC (38:1)
[M+H] +
PC (36:5)
[M+H] +
PC (36:3)
[M+H] +
PC (36:2)
[M+H] +
PC (36:4; O)
[M+H] +
PC (40:1)
[M+H] +
??
PC (36:1)
[M+H] +
PC (40:0)
[M+H] +
CE 16:1
[M+H] +
??

Change trend (↑↓)
NC-NA vs CNA

C-NA vs CA

NC
NC
NC

↑
↑
↑

NC

↑

NC

↑

NC

↑

NC

↓

NC

↑

NC
↓

↓
↑

↓

↑

NC

↑

NC

↑

Table 3. 6.List of integrating enrichment analysis pathways of fatty acids and lipids using
MetaboAnlyst 5.0.
Pathway name

Match status
In
In
set background
2
4
3
36

Linoleic acid metabolism
Biosynthesis of
unsaturated fatty acids
Primary bile acid
2
46
biosynthesis
Alpha-linolenic acid
1
13
metabolism
Arachidonic acid
1
32
metabolism
Glycerophospholipids
1
35
metabolism
Steroid biosynthesis
1
42
Abbreviation: FDR= false discovery rate.

P-value

-log
(P)

FDR

Impact

Pathway
KEGG ID

1.98E-4
4.62E-4

3.92
3.33

0.017
0.019

1.0
0.0

gga00591
gga01040

0.018

1.72

0.52

0.082

gga00120

0.061

1.21

1.0

0.0

gga00592

0.145

0.83

1.0

0.0

gga00590

0.15

0.80

1.0

0.085

gga00564

0.18

0.72

1.0

0.0

gga00100
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Table 3. 7.List of significantly changed metabolites (C-NA vs. CA) with their retention time (RT), molecular mass to charge ratio (m/z), pvalue or t-test, the fold change (FC), the compound name and formula, the identification number (HMDB ID, KEGG ID, BioCyc ID, catalog
number, LM ID). Values with the red color show significant differentiation of the listed small molecules (p<0.05). The up arrow (↑) is the
upregulated small molecules in C-NA relative to CA, while the down arrow (↓) is the downregulated small molecules in C-NA vs. CA.
Retention
time (RT)
(min)

m/z
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FC
(NCNA vs
CNA)
0.240

p-values
(C-NA
vs CA)

FC
(CNA vs
CA)

Small molecules
(name+ formula)

Compound

857.367

pvalues
(NCNA vs
C-NA)
0.061

0.016

4.010

Ubiquitin

Gene ID: 395796

Change
trend
(↑↓)
(C-NA vs
CA)
↓

14.981
26.744

263.088

0.102

0.514

0.017

2.477

CPD-20353

↓

26.751

369.171

0.112

0.572

0.025

2.101

C04555

↓

35.927

478.303

0.002

1.601

2.68E-06

0.268

LMGP02050011

↑

36.205

520.339

0.075

1.496

0.015

0.513

LMGP01050035

↑

38.832

496.339

0.001

1.215

0.708

LMGP01050074

↑

39.075

522.361

0.102

1.617

1.549E05
0.033

LMGP01050079

↑

45.319

482.323

0.007

1.465

7.45E-06

0.330

LMGP01080020

↑

58.239

621.311

0.789

1.079

0.046

0.520

L-aspartyl-L-glutamate
(C9H12N2O7)
Dehydroepiandrosterone sulfate
(C19H28O5S)
PE (18:2(9Z,12Z)/0:0)
(C23H44NO7P)
PC (18:2(9Z,12Z) \/0:0)
(C26H50NO7P)
PC (0:0/16:0)
(C24H50NO7P)
PC (0:0/18:1(6Z))
(C26H52NO7P)
PC (14:0/O-1:0)
(C23H48NO7P)
LysoPI(20:4(5Z,8Z,11Z,14Z)/0:0)
(C27H51O12)

HMDB0061690

↑

0.494

Table 3. 8.List of integrating enrichment analysis pathways of small molecules using MetaboAnlyst
5.0.
Pathway name

Glycerophospholipids
metabolism
Steroid hormone
biosynthesis

Match status
In
In
set background
1
35

p-value

-log
(P)

FDR

Impact

Pathway
KEGG ID

0.047

1.32

1.0

0.031

gga00564

1

0.09

01.01

1.0

0.0

gga00140

71

Table 3. 9.Significant information related to the small molecule (ubiquitin) using KEGG, UniProt,
and David Functional Annotation Bioinformatics Microarray Analysis.
Pathway ID
gga03010

Pathway name
Ribosome

Count in
network

FDR

10

1.15e-18
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Functional annotation
linked to biological process
DNA repair
Modification-dependent
protein catabolic process
Protein ubiquitination
Translation

144
Figure 3. 1.Flow chart of the experimental design. A total of 27 birds at 2 weeks of age were used in this study. The plasma samples
were collected from three different groups (NC-NA, C-NA, CA) for proteomic and metabolomic studies. Proteins, total fatty acids,
lipids, and small molecules were extracted and submitted for mass spectrometry analyses.

Figure 3. 2.SDS-PAGE analysis for fast-growing broiler proteins. Lanes 1,2, and 3 are protein
samples from the NC-NA group, lanes 4,5, and 6 are protein samples from the C-NA group, and
lanes 7, 8, and 9 are protein samples from the CA group.
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A.

B.

Figure 3. 3.Venn diagrams illustrate the common and differentially expressed proteins in the
three major groups (NC-NA, C-NA, CA); (A) is the individual proteins based on the presence
and absence; (B) is the individual proteins based on the quantitative profile.
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-1
-2
-3
-4
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GO TERM ( BIOLOGICAL PROCESS)
UPREGULATED PROTEINS

DOWNREGULATED PROTEINS

Figure 3. 4.Upregulated and downregulated proteins in different biological processes contribute to ascites induction in fastgrowing broilers.

Figure 3.5.The protein-protein interactions (the interaction between upregulated and
downregulated proteins) using STRING.
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Oleic acid

Stearic acid

Linoleic acid

Figure 3. 6.GC-MS total ion analysis of plasma free fatty acids (FFAs) from NC-NA, C-NA,
and CA groups. Each peak corresponds to specific fatty acids. Three FFAs show significant
differentiation (p-value <0.05) in C-NA vs. CA but not in NC-NA vs. C-NA (red circle).
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Figure 3. 7.Venn diagram shows the common and significantly changed lipids (based on the
quantitative profile).
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Volcano Plot (NC-NA/C-NA)
3

-Log10 p-value

2.5
PC (40:0)

p=0.05

2
PC(36:1)

1.5
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0.5
0

-2

-1.5

-1

-0.5

0

0.5

1

1.5

2

Log2 FC (NC-NA/C-NA)
Figure 3. 8.The volcano plot shows the lipid compositions of plasma samples from NC-NA
vs. C-NA. The ratio of intensity for peaks from NC-NA and C-NA samples were plotted in the xaxis [log2(NC-NA/C-NA)]. The y axis represents the negative logarithm “base 10” of the p-value
or t-test. The data points with highly significant differences (low p-values) represent above the red
horizontal line (p<0.05). Upregulated lipids are on the positive (right) side of the red horizontal
line, while downregulated lipids are on the negative (left) side of the red horizontal line.
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Volcano Plot (C-NA/CA)
3
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??1.5
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Log2 FC (C-NA/CA)
Figure 3. 9.The volcano plot shows the lipid compositions of plasma samples from C-NA vs.
CA. The ratio of intensity for peaks from C-NA and CA samples were plotted in the x-axis
[log2(C-NA/CA)]. The y axis represents the negative logarithm “base 10” of the p-value or t-test.
The data points with highly significant differences (low p- values) represent above the red
horizontal line (p<0.05). Upregulated lipids are on the positive (right) side of the red horizontal
line, while downregulated lipids are on the negative (left) side of the red horizontal line.
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Figure 3. 10.The overview of metabolic pathways which induced ascites or pulmonary
hypertension based on SMPDB. The metabolic analysis was performed using downregulated and
upregulated fatty acids and lipids.
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Figure 3.11. The Venn diagram shows the common and significantly different small
molecules based on the quantitative profile.
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The Classification of Small Molecules

11%

11%
11%
Dipeptide
Steroid hormone
Glycerophospholipids

67%

Small proteins

Figure 3. 12.A pie chart shows different classifications of small molecules.
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Volcano Plot (NC-NA/C-NA)
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Figure 3. 13.The volcano plot shows the small molecules in plasma samples from NC-NA vs.
C-NA. The ratio of intensity for peaks from NC-NA and C-NA samples were plotted in the x-axis
[log2(NC-NA/C-NA)]. The y axis represents the negative logarithm “base 10” of the p-value or ttest. The data points with highly significant differences (low p-values) represent above the red
horizontal line (p<0.05). Upregulated small molecules are on the positive (right) side of the red
horizontal line, while downregulated small molecules are on the negative (left) side of the red
horizontal line.
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Volcano Plot (C-NA/CA )

Dehydroepiandrosterone sulfate

6

PE (18:2(9Z,12Z)/0:0)

PC (0:0/16:0)

PC (14:0/O-1:0)

5

-Log10 p-value

L-aspartyl-L-glutamate
4

PC (0:0/16:0)

3
LysoPI(20:4(5Z,8Z,11Z,1
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2

Ubiquitin

PC (18:2(9Z,12Z) \/0:0)
PC (0:0/18:1(6Z))
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Figure 3. 14.The volcano plot shows small molecules in plasma samples from C-NA vs. CA.
The ratio of intensity for peaks from C-NA and CA samples were plotted in the x-axis [log2(CNA/CA)]. The y axis represents the negative logarithm “base 10” of the p-value or t-test. The data
points with highly significant differences (low p-values) represent above the red horizontal line
(p<0.05). Upregulated small molecules are on the positive (right) side of the red horizontal line,
while downregulated small molecules are on the negative (left) side of the red horizontal line.
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CHAPTER 4
Summary & Conclusion
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Poultry meat is a valuable food because it is rich in high nutritional value. It is a good
source of digestible proteins with a minimal level of collagen (Kralik et al., 2018). The poultry
meat is a good source of moderate energy content and contains unsaturated lipids, minerals such
as,” zinc, copper, and iron,” and essential vitamins such as “pantothenic acid, vitamin B 6, and
thiamin”. Several epidemiological studies showed a strong association between good health and
consumption of poultry meat since it has reduced the development of obesity and overweight, type
2 diabetes, and cardiovascular diseases (Marangoni et al., 2015; Richi et al., 2015). In the 1990s,
chickens were genetically selected in both Europe and the USA for particular traits such as eggs
and meat production (Elfick, 2012). Selective breeding helps study the mechanism of tissue
growth, lowering the time and reducing the cost of raising each flock (Tallentire et al., 2016). In
the early stage of the genetic selection, geneticists were able to change the birds’ phenotypes,
reduce the mortality rate, and control diseases that affect the poultry (Flock et al., 2005).

There are different metabolic diseases associated with rapid growth and genetic selections
which have existed in the poultry industry for more than 30 years. Examples of these are fatty liver
and kidney syndrome, skeleton diseases, and ascites or pulmonary hypertension (Leshchinsky &
Klasing, 2001). Ascites syndrome or pulmonary hypertension syndrome is a consequence of
genetic selection for higher body mass (Smith et al., 1954). Broilers with ascites syndrome are
characterized by having a big belly due to the accumulation of fluid in the abdominal cavity. It is
a serious issue in the poultry industry because the mortality rate of broilers was 30%, and the
economic loss was estimated to be $100 annually (Pavlidis et al., 2007).

In 1994, Dr.Anthony and his colleagues (at the University of Arkansas, Department of
Poultry Science) initiated the selection program for ascites development. Essentially, chickens
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from an elite commercial line were raised in a hypobaric chamber to mimic the high altitude
(9000ft above sea level). The hypobaric chamber was provided with a partial vacuum to decrease
the partial oxygen pressure and induce ascites. Susceptible to ascites (SUS line) and resistant to
ascites (RES line) is the main genetic lines that were developed for further studies (Balog et al.,
2000; Tellez et al., 2005; Pavlidis et al., 2007).

In our lab, several studies were performed to examine the genetic basis of the ascites
phenotype. To begin, a second-generation (F2) was generated through double reciprocal crosses
of RES and SUS lines. Then, a genome-wide SNP was performed to find chromosomal regions
associated with PHS susceptibility. The statistical analysis illustrated a relationship between a
region on chromes 9 (12 to 13Mbp) and ascites phenotype in both experimental lines (RES and
SUS) and the commercial line. The susceptibility to ascites was gender-specific because females
were more affected than males. Several candidate genes were involved in this region, such as
urotensin 2 domain (UTS2D), an angiotensin II type 1 receptor (AGTR1), and Serotonin
Receptor/Transporter type 2B (5HT2B) (Burks et al., 2011; Wideman et al., 2013; Krishnamoorthy
et al., 2014). Another genome-wide association study was conducted by Dey et al. (2017) and
illustrated a significant relationship between chromosome 9 (11.8 to 13.6Mbp) and ascites. Within
this region, two candidate genes (UTS2D and AGTR1) were identified earlier and confirmed by
Dey et al. (2017) to be associated with ascites. Another subsequent genome-wide association study
was done on unselected relax lines at 16 and 18 generations. Two significant regions on
chromosome Z and chromosome 2 were found to be relevant to ascites (Tarrant et al., 2017). A
whole-genome resequencing study was conducted by our research group, which identified 31
regions associated with ascites. One of which is the carboxypeptidase Q (CPQ) gene on
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chromosome 2 (127.62 to 127.75 Mbp) (Dey et al., 2018). This gene has been used in markerassisted selection studies (manuscript under review).
Chapter 2 summarizes the CPQ gene expression data of relaxed unselected line, where we
measured the gene expression in eight tissues (heart, liver, kidney, thigh, breast, spleen, lung,
thymus) using RT-qPCR. Then, the gene expression data were normalized to the reference gene
TATA-box binding protein (TBP) gene. We found that CPQ gene expression level was
significantly increased in the liver of homozygous non-ref males. However, there are no significant
differences in the CPQ expression level in other tissues from homozygous non-ref males and all
tissues from homozygous non-ref females. We could not measure the gene expression of
heterozygous samples. Therefore, further analysis was done on previous next-generation
sequencing data to determine if there is a copy number variation or a chromosomal deletion
affecting the gene expression. Based on reading depth analysis of our next-generation sequence
data, some broilers carry a CPQ gene deletion spanning from intron 4 to ~40 kbp downstream of
exon 8. The size of the deletion was estimated to be ~125Kbp. A TaqMan assay was designed to
genotype the birds for the deletion and investigate the association of this deletion with the ascites
phenotype. PCR primers were developed to span the deleted region allowing us to fine map the
exact limits of the deletion, which appear to have resulted from the recombination of two CR1
repeats. This chromosomal deletion is still a candidate region for future study of relevance to
ascites or pulmonary hypertension in broilers. Our new findings give significant hints to
recognizing the mechanisms that underlie this deletion and affect the ascites phenotypes.
Chapter 3 summarizes the mass spectrometry data, where we analyzed the proteomic and
metabolomic changes for 18 male birds (6 no challenged with no ascites “NC-NA” vs. 6 challenged
with no ascites “C-NA” vs. 6 challenged with ascites “CA”). The major aim of this chapter is to
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identify noninvasive biomarkers for early ascites detection. The p-values less than 0.05 from the
student T-test were used to determine the significantly changed proteins/metabolites. We were
able to identify eight upregulated proteins ( apolipoprotein A-I “APOA1”, ovotransferrin “TF”,
hemoglobin subunit beta “HBBA”, beta-2-glycoprotein 1 precursor “a protein induced by APOH
gene”, angiotensinogen “AGT”, peroxiredoxin-1 “PRDX1”, calcium-binding protein “P22”,
prothrombin “F2”, coagulation factor IX “F9”) and nine downregulated proteins (fibrinogen alpha
chain “FGA”, fibrinogen gamma chain precursor “FGG”, fibrinogen beta chain “FGB”,
fibronectin “FN1”, IgG Fc-binding protein “FcγBP”, complement factor H isoform X1 “produced
by CFH gene”, glutathione peroxidase “GPX3”, von Willebrand factor precursor “VWF”) in CNA vs. CA with the onset of ascites. The level of some fatty acids (stearic acid “C18:0”, oleic acid
“C18:1”, linoleic acid “C18:2”) was upregulated in C-NA vs. CA with respect to ascites. We could
identify a large number of lipids and small molecules which were upregulated in C-NA vs. CA in
response to ascites. Examples of the upregulated lipids are phosphatidylcholine “PC” (34:2), PC
(38:3), PC (38:1), PC (36:5), PC (36:3), PC (36:2), PC (40:1), PC (36:1), PC (40:0), and cholesterol
ester “CE” (16:1). Examples of small molecules are PC (18:2(9Z,12Z) \/0:0), PC (0:0/18:1(6Z),
LysoPI

(20:4(5Z,8Z,11Z,14Z)/0:0),

PC

(0:0/16:0),

phosphatidylethanolamine

“PE”

(18:2(9Z,12Z)/0:0), and PC (14:0/O-1:0). Furthermore, PC (36:4; O) was the only lipid that was
downregulated with the onset of ascites. Three small molecules (ubiquitin, L-aspartyl-Lglutamate, dehydroepiandrosterone) were downregulated in C-NA vs. CA. Most of the identified
proteins/metabolites are candidate biomarkers that explain how ascites evolve in broiler chickens.
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